<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Aging Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Aging Dis</journal-id>
<journal-title-group>
<journal-title>Aging and Disease</journal-title>
</journal-title-group>
<issn pub-type="epub">2152-5250</issn>
<publisher>
<publisher-name>JKL International LLC</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28580188</article-id>
<article-id pub-id-type="pmc">5440112</article-id>
<article-id pub-id-type="publisher-id">ad-8-3-334</article-id>
<article-id pub-id-type="doi">10.14336/AD.2016.1030</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson’s Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hipkiss</surname>
<given-names>Alan R.</given-names>
</name>
<xref ref-type="corresp" rid="cor1-ad-8-3-334">
<sup>*</sup>
</xref>
<aff id="aff1-ad-8-3-334">Aston Research Centre for Healthy Ageing (ARCHA), School of Health and Life Sciences, Aston University, Birmingham B4 7ET, United Kingdom.</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1-ad-8-3-334"><label>*</label>Correspondence should be addressed to: Dr. Alan R. Hipkiss, Aston Research Centre for Healthy Ageing (ARCHA), School of Health and Life Sciences, Aston University, Birmingham B4 7ET, United Kingdom. Email: <email>alanandjill@lineone.net</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>2</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<issue>3</issue>
<fpage>334</fpage>
<lpage>345</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="rev-request">
<day>20</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2017 Hipkiss, et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<abstract>
<p>Recent research shows that energy metabolism can strongly influence proteostasis and thereby affect onset of aging and related disease such as Parkinson’s disease (PD). Changes in glycolytic and proteolytic activities (influenced by diet and development) are suggested to synergistically create a self-reinforcing deleterious cycle via enhanced formation of triose phosphates (dihydroxyacetone-phosphate and glyceraldehyde-3-phosphate) and their decomposition product methylglyoxal (MG). It is proposed that triose phosphates and/or MG contribute to the development of PD and its attendant pathophysiological symptoms. MG can induce many of the macromolecular modifications (e.g. protein glycation) which characterise the aged-phenotype. MG can also react with dopamine to generate a salsolinol-like product, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinaline (ADTIQ), which accumulates in the Parkinson’s disease (PD) brain and whose effects on mitochondria, analogous to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), closely resemble changes associated with PD. MG can directly damage the intracellular proteolytic apparatus and modify proteins into non-degradable (cross-linked) forms. It is suggested that increased endogenous MG formation may result from either, or both, enhanced glycolytic activity and decreased proteolytic activity and contribute to the macromolecular changes associated with PD. Carnosine, a naturally-occurring dipeptide, may ameliorate MG-induced effects due, in part, to its carbonyl-scavenging activity. The possibility that ingestion of highly glycated proteins could also contribute to age-related brain dysfunction is briefly discussed.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Parkinson’s</kwd>
<kwd>methylglyoxal</kwd>
<kwd>glycolysis</kwd>
<kwd>mitochondria</kwd>
<kwd>proteolysis</kwd>
<kwd>glycation</kwd>
<kwd>homeostasis</kwd>
<kwd>carnosine</kwd>
<kwd>aging</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The objective of this opinion piece is to offer possible answers to the question “why is ageing a risk factor for Parkinson’s disease?” It is suggested that (i) excessive glycolysis accelerates aging onset caused in part by increased generation of the triose phosphates dihydroxyacetone-phosphate and glyceraldehyde-3-phosphate, and their decomposition product methylglyoxal (MG), (ii) MG causes mitochondrial dysfunction and provokes a compensatory, but eventually deleterious, increase in glycolysis, (iii) the developmentally-related decline in proteostasis (cytosolic and mitochondrial) synergistically induce a self-reinforcing deleterious cycle of dysfunction which increase the risk of aging generally and PD in particular, and (iv) increased MG accumulation in substantia nigra promotes formation of a neurotoxin found in the brains of PD patients and diabetics.</p>
<sec>
<title>Glycolysis is a risk factor</title>
<p>It is becoming increasingly apparent that the glycolytic pathway is not a benign sequence of reactions [<xref ref-type="bibr" rid="b1-ad-8-3-334">1</xref>,<xref ref-type="bibr" rid="b2-ad-8-3-334">2</xref>]. There is considerable evidence showing that aging, in many species, can be delayed by dietary interventions which impact particularly on glycolysis. Studies in various organisms show that lifespan can be increased when glycolytic flux is partially inhibited [<xref ref-type="bibr" rid="b3-ad-8-3-334">3</xref>], due to either permanent caloric restriction [<xref ref-type="bibr" rid="b4-ad-8-3-334">4</xref>] or every-other-day feeding (i.e. intermittent fasting) [<xref ref-type="bibr" rid="b5-ad-8-3-334">5</xref>,<xref ref-type="bibr" rid="b6-ad-8-3-334">6</xref>], deficiency in insulin-signalling [<xref ref-type="bibr" rid="b3-ad-8-3-334">3</xref>,<xref ref-type="bibr" rid="b7-ad-8-3-334">7</xref>], and treatment with either a non-metabolisable glucose analogue (2-deoxyglucose) [<xref ref-type="bibr" rid="b8-ad-8-3-334">8</xref>] or the mTOR inhibitor rapamycin [<xref ref-type="bibr" rid="b9-ad-8-3-334">9</xref>-<xref ref-type="bibr" rid="b11-ad-8-3-334">11</xref>]. Although the mechanism(s) responsible for these effects is/are still debated, there is increasing evidence that decreased generation of methylglyoxal (MG), arising because of lowered glycolytic activity, could, at least in part, explain the beneficial effects on lifespan and onset of much age-related dysfunction and pathology [<xref ref-type="bibr" rid="b2-ad-8-3-334">2</xref>,<xref ref-type="bibr" rid="b12-ad-8-3-334">12</xref>-<xref ref-type="bibr" rid="b15-ad-8-3-334">15</xref>].</p>
<p>MG is a by-product of glycolysis, formed predominantly by the spontaneous decomposition of the triose-phosphates glyceraldehyde-3-phosphate and dihydroxyacetone-phosphate, both of which are normal glycolytic intermediates; MG can also arise from catabolism of the amino acids serine and threonine and from lipid peroxidation. Animal studies have shown that tissue levels of MG are strongly raised following high glycemic-index meals [<xref ref-type="bibr" rid="b16-ad-8-3-334">16</xref>,<xref ref-type="bibr" rid="b17-ad-8-3-334">17</xref>], hyperglycaemic episodes [<xref ref-type="bibr" rid="b18-ad-8-3-334">18</xref>] and intake of high levels of fructose [<xref ref-type="bibr" rid="b19-ad-8-3-334">19</xref>]. Furthermore, MG levels in erythrocytes from diabetic patients have been shown to be increased at least 15-fold compared to controls, possibly due to decreased glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity [<xref ref-type="bibr" rid="b20-ad-8-3-334">20</xref>,<xref ref-type="bibr" rid="b21-ad-8-3-334">21</xref>]. It is also possible that catalytic function of the glycolytic enzyme triose-phosphate isomerase (TPI) may decline due to activity-induced asparagine deamidation; insufficient TPI activity could cause accumulation of dihydroxyacetone phosphate and contribute to increased MG generation following spontaneous decomposition of the triose phosphate [<xref ref-type="bibr" rid="b22-ad-8-3-334">22</xref>,<xref ref-type="bibr" rid="b23-ad-8-3-334">23</xref>]. Given that protein synthesis cannot occur in human erythrocytes, the possibility arises that excessive and persistent glycolysis due to constant hyperglycemia consequent upon almost continuous carbohydrate intake could lower TPI activity to such a degree that MG accumulates. This proposal therefore suggests that erythrocytes could be a major source of MG [<xref ref-type="bibr" rid="b24-ad-8-3-334">24</xref>] during persistent hyperglycemia.</p>
<p>It is interesting to note that when the relative activities of the glycolytic enzymes are compared, TPI activity in erythrocytes is almost 4-fold greater than any other glycolytic enzyme [<xref ref-type="bibr" rid="b25-ad-8-3-334">25</xref>]. Such elevated TPI activity may reflect an evolutionary adaptation to the likelihood of metabolically-induced decline in TPI activity during the erythrocyte lifespan, prior to its eventual removal after 120 days (in humans). However, as a result increased reliance upon carbohydrate, especially in the so-called Western diet, it can be argued that human diets have radically changed compared to food intake during the majority of human evolution. Consequently, it is possible that the initial excess of TPI within human erythrocytes is insufficient to compensate for the enhanced rate of TPI inactivation induced by the overall increase in glycolysis which occurs because of the Western diet. Such a proposal could contribute to the increased incidence of metabolic disease in which MG appears to play a predominant role.</p>
<p>It has been shown that fibroblasts obtained from PD patients possess defects in energy metabolism and proteostasis [<xref ref-type="bibr" rid="b26-ad-8-3-334">26</xref>] and it is possible that increased MG generation contributes to both deficiencies. While an in-depth review of MG’s reactivity and biological effects is beyond the scope of this brief opinion piece, one can safely state that MG is a reactive bicarbonyl [<xref ref-type="bibr" rid="b27-ad-8-3-334">27</xref>], whose action on cells and tissues mimics many of the effects of aging [<xref ref-type="bibr" rid="b24-ad-8-3-334">24</xref>,<xref ref-type="bibr" rid="b28-ad-8-3-334">28</xref>,<xref ref-type="bibr" rid="b29-ad-8-3-334">29</xref>], and is therefore increasingly regarded as causal to much age-related dysfunction including neurodegeneration [<xref ref-type="bibr" rid="b30-ad-8-3-334">30</xref>,<xref ref-type="bibr" rid="b31-ad-8-3-334">31</xref>]. The effect of MG on proteins is the formation of advanced glycation end-products (AGEs) following its reaction with lysine, arginine, histidine and cysteine residues [<xref ref-type="bibr" rid="b32-ad-8-3-334">32</xref>]; the resultant glycated proteins become resistant to intracellular proteolysis if they become cross-linked [<xref ref-type="bibr" rid="b33-ad-8-3-334">33</xref>]. Not only can MG promote formation of undegradable proteins but the bicarbonyl can also inhibit intracellular proteolytic activity towards other aberrant proteins [<xref ref-type="bibr" rid="b34-ad-8-3-334">34</xref>,<xref ref-type="bibr" rid="b35-ad-8-3-334">35</xref>,<xref ref-type="bibr" rid="b36-ad-8-3-334">36</xref>]. MG can directly compromise ubiquitin function by reacting with lysine residue 78, thereby inhibiting attachment of further ubiquitin molecules [<xref ref-type="bibr" rid="b17-ad-8-3-334">17</xref>]. MG can also react with mitochondria to provoke organelle dysfunction accompanied by increased ROS generation [<xref ref-type="bibr" rid="b13-ad-8-3-334">13</xref>,<xref ref-type="bibr" rid="b28-ad-8-3-334">28</xref>,<xref ref-type="bibr" rid="b37-ad-8-3-334">37</xref>,<xref ref-type="bibr" rid="b38-ad-8-3-334">38</xref>]; one likely effect is a compensating increase in glycolysis in order to maintain sufficient ATP synthesis, but which exacerbates the situation by increasing MG formation.</p>
</sec>
<sec>
<title>Methylglyoxal and PD</title>
<p>There is increasing evidence to suggest that excess carbohydrate catabolism may be causal to PD [<xref ref-type="bibr" rid="b39-ad-8-3-334">39</xref>,<xref ref-type="bibr" rid="b40-ad-8-3-334">40</xref>], possibly due to raised levels of MG. Dunn et al. proposed that an early event in spontaneous PD is dysregulation of glucose metabolism [<xref ref-type="bibr" rid="b41-ad-8-3-334">41</xref>]. There are also reports that diets which are of low glycemic index may decrease PD risk [<xref ref-type="bibr" rid="b42-ad-8-3-334">42</xref>-<xref ref-type="bibr" rid="b46-ad-8-3-334">46</xref>]. Interestingly, the protein Parkin, a mutation in which increases PD risk, strongly affects energy metabolism: overexpression of Parkin inhibits glycolysis and stimulates mitochondrial activity, whilst loss of Parkin function results in decreased mitochondrial activity and increased glycolysis [<xref ref-type="bibr" rid="b47-ad-8-3-334">47</xref>,<xref ref-type="bibr" rid="b48-ad-8-3-334">48</xref>,<xref ref-type="bibr" rid="b49-ad-8-3-334">49</xref>,<xref ref-type="bibr" rid="b50-ad-8-3-334">50</xref>]. Additionally, it has been found that PINK1 deficiency (implicated in familial PD onset) stimulates glycolysis via stabilization of hypoxia-inducible factor-1alpha (HIF1-alpha) [<xref ref-type="bibr" rid="b51-ad-8-3-334">51</xref>].</p>
<p>It is also interesting to note that PD is frequently associated with increased protein glycation [<xref ref-type="bibr" rid="b28-ad-8-3-334">28</xref>,<xref ref-type="bibr" rid="b31-ad-8-3-334">31</xref>,<xref ref-type="bibr" rid="b52-ad-8-3-334">52</xref>,<xref ref-type="bibr" rid="b53-ad-8-3-334">53</xref>] especially of α-synuclein which accumulates in PD brain as Lewy bodies [<xref ref-type="bibr" rid="b30-ad-8-3-334">30</xref>,<xref ref-type="bibr" rid="b49-ad-8-3-334">49</xref>,<xref ref-type="bibr" rid="b54-ad-8-3-334">54</xref>,<xref ref-type="bibr" rid="b55-ad-8-3-334">55</xref>]. Additionally, it has been shown that mutation in the DJ-1 gene is a PD risk factor: a study by Shi et al. has shown that DJ-1 deficiency activates glycolysis in muscle by inducing a Warburg-like metabolic reprogramming [<xref ref-type="bibr" rid="b56-ad-8-3-334">56</xref>]; while another recent study showed that loss of DJ-1 function disrupts mitochondrial function, whereas DJ-1 activity represses glycolysis [<xref ref-type="bibr" rid="b57-ad-8-3-334">57</xref>]. Interestingly a member of the DJ-1 superfamily (Hsp-31) has been reported to repair proteins modified by MG [<xref ref-type="bibr" rid="b58-ad-8-3-334">58</xref>].</p>
<p>Glyoxalase-1 is an important enzyme for MG destruction [<xref ref-type="bibr" rid="b59-ad-8-3-334">59</xref>,<xref ref-type="bibr" rid="b60-ad-8-3-334">60</xref>] and glyoxalase-1 activity has been found to decline with age in rodent tissues [<xref ref-type="bibr" rid="b61-ad-8-3-334">61</xref>], during senescence of cultured human fibroblasts [<xref ref-type="bibr" rid="b62-ad-8-3-334">62</xref>] and in the human brain [<xref ref-type="bibr" rid="b63-ad-8-3-334">63</xref>], while changes in glyoxalase-1 activity in <italic>C. elegans</italic> has been shown to strongly influence both mitochondrial function and organism lifespan [<xref ref-type="bibr" rid="b64-ad-8-3-334">64</xref>].</p>
<p>Not only can MG directly damage mitochondria [<xref ref-type="bibr" rid="b65-ad-8-3-334">65</xref>,<xref ref-type="bibr" rid="b66-ad-8-3-334">66</xref>] and may be associated with age-related cognitive decline [<xref ref-type="bibr" rid="b67-ad-8-3-334">67</xref>], but the bicarbonyl can also react with dopamine [<xref ref-type="bibr" rid="b68-ad-8-3-334">68</xref>,<xref ref-type="bibr" rid="b69-ad-8-3-334">69</xref>] to form 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydro-isoquinaline (ADTIQ), which is a salsolinol-like compound [<xref ref-type="bibr" rid="b69-ad-8-3-334">69</xref>]. ADTIQ not only accumulates in PD brains but also mimics the effects of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) whose effects on mitochondria resemble the changes associated with PD [<xref ref-type="bibr" rid="b69-ad-8-3-334">69</xref>]. Further evidence supporting the proposed link between MG, dopamine and generation of the neurotoxin ADTIQ is shown by the increased levels of glycolytic enzymes, MG and ADTIQ in the brains of diabetic rats [<xref ref-type="bibr" rid="b70-ad-8-3-334">70</xref>]. It may be relevant to note that another group of nigrostriatal neurotoxins, N-methylated-beta-carboline and 2,9-dimethyl beta-carboline, whose structures resembles MPTP, not only inhibit mitochondria respiration but are also potent inhibitors of triosephosphate isomerase (TPI) [<xref ref-type="bibr" rid="b71-ad-8-3-334">71</xref>]. Inhibition of TPI provokes accumulation of dihydroxyacetone-phosphate which is not only a strong glycating agent but spontaneously decomposes into MG and has been proposed to contribute to neurodegeneration associated with Alzheimer’s disease [<xref ref-type="bibr" rid="b72-ad-8-3-334">72</xref>,<xref ref-type="bibr" rid="b73-ad-8-3-334">73</xref>]. As outlined above, it is also possible that TPI activity could decline due to over-use of the enzyme inducing deamidation of two asparagine residues in the enzyme (a wear and tear phenomenon) [<xref ref-type="bibr" rid="b22-ad-8-3-334">22</xref>,<xref ref-type="bibr" rid="b23-ad-8-3-334">23</xref>], ultimately resulting in dihydroxyacetone-phosphate accumulation and increased MG formation.</p>
<p>In a study using mice fed a high glycemic-index diet, it was found that protein damage was increased in the retina and in the substantia nigra (presumed to be induced by MG or other endogenous glycating agents) up to 34-fold compared to animals fed a low glycemic-index diet [<xref ref-type="bibr" rid="b17-ad-8-3-334">17</xref>]; however, this remarkable observation has been neither confirmed nor refuted in other laboratories studying the effect of dietary glycemic-index on brain protein modification. Notwithstanding this caveat, it reasonable to at least consider whether metabolic changes which influence aging via a raised potential for MG accumulation will, by reacting with dopamine, not only decrease dopamine levels in the substantia nigra but also increase the likelihood of further mitochondrial dysfunction and enhance the generation of those changes which characterise PD.</p>
<p>Although MG is regarded as a potential source of protein dysfunction, principally via glycation, it is uncertain whether direct MG ingestion can result in its survival and transport across the gut wall in sufficient quantities to provoke dysfunction [<xref ref-type="bibr" rid="b74-ad-8-3-334">74</xref>,<xref ref-type="bibr" rid="b75-ad-8-3-334">75</xref>]. In contrast, however, other studies have shown that diets containing high levels of glycated proteins (produced by MG treatment) can not only suppress the lifespan-extending effects of dietary restriction in mice [<xref ref-type="bibr" rid="b76-ad-8-3-334">76</xref>], but also deleteriously affect memory in older humans [<xref ref-type="bibr" rid="b77-ad-8-3-334">77</xref>,<xref ref-type="bibr" rid="b78-ad-8-3-334">78</xref>].</p>
<p>Interestingly, there are hints in the literature suggesting a link between PD and AGE receptors (RAGEs): RAGE ablation or deficiency is protective towards murine dopaminergic neurons in a MPTP model of PD [<xref ref-type="bibr" rid="b79-ad-8-3-334">79</xref>,<xref ref-type="bibr" rid="b80-ad-8-3-334">80</xref>], and certain RAGE polymorphisms are associated with either susceptibility or protection against PD in Chinese Han populations [<xref ref-type="bibr" rid="b52-ad-8-3-334">52</xref>]. The flavenoid myricitrin, which has been claimed to exert anti-PD activity, also alleviates MG-induced mitochondrial dysfunction, AGE formation and RAGE expression [<xref ref-type="bibr" rid="b81-ad-8-3-334">81</xref>]. These findings support the present contention that MG may play an important role in PD causation.</p>
<p>That dietary glycated proteins, but not, perhaps, free dietary MG [<xref ref-type="bibr" rid="b74-ad-8-3-334">74</xref>,<xref ref-type="bibr" rid="b75-ad-8-3-334">75</xref>], are reported to be deleterious, raises the controversial possibility that intact glycated proteins could bind to RAGEs present on cells of digestive tract, thereby traverse the gut wall, to enter the enteric nervous system and then transfer to the CNS [<xref ref-type="bibr" rid="b82-ad-8-3-334">82</xref>,<xref ref-type="bibr" rid="b83-ad-8-3-334">83</xref>]. Furthermore, it is known that certain misfolded proteins, such as α-synuclein, can undergo cell-to-cell tranmission, analogous to prion proteins [<xref ref-type="bibr" rid="b84-ad-8-3-334">84</xref>,<xref ref-type="bibr" rid="b85-ad-8-3-334">85</xref>,<xref ref-type="bibr" rid="b86-ad-8-3-334">86</xref>]. Whilst such a scenario may be regarded as somewhat speculative, these observations raise important and possibly alarming questions regarding the presence of highly glycated proteins in human diets with respect to neurodegenerative conditions, especially given recent findings of the effects of dietary glycated proteins on memory in elderly humans [<xref ref-type="bibr" rid="b78-ad-8-3-334">78</xref>].</p>
</sec>
<sec>
<title>Aging, proteostatic dysfunction and PD</title>
<p>Changes in protein quality control (via the ubiquitin/proteasomal, autophagic and mitophagic systems, together with chaperone proteins etc.) contribute to both aging generally and PD in particular [<xref ref-type="bibr" rid="b87-ad-8-3-334">87</xref>-<xref ref-type="bibr" rid="b90-ad-8-3-334">90</xref>]. Vulnerability to proteostatic dysfunction may increase with age due to the following scenario. As growth ceases when adulthood is approached, the rate of protein biosynthesis declines. It is suggested that the synthesis of the many necessary proteases, chaperone proteins and other factors required to ensure maintenance of protein quality [<xref ref-type="bibr" rid="b91-ad-8-3-334">91</xref>], is likely to decline co-ordinately with ribosome numbers and overall protein biosynthesis rates [<xref ref-type="bibr" rid="b92-ad-8-3-334">92</xref>]. (This has been observed in the bacterium <italic>Escherichia coli</italic> - see below). The nascent polypeptide-associated complex (NAC) is a eukaryotic chaperone protein complex which recognises misfolded proteins while still associated with the ribosome; NAC normally exists in equimolar levels with ribosomes, binding in a 1:1 ratio [<xref ref-type="bibr" rid="b93-ad-8-3-334">93</xref>]. Consequently, any decline in the synthesis of NAC and other necessary chaperones etc. will lead to a decrease in the maximum available activity for the recognition and proteolytic elimination of aberrant proteins of any origin i.e. those arising because of biosynthetic errors, as well as those damaged post-synthetically by ROS or glycating agents such as MG. That chaperone proteins, e.g. hsc70 and hsp27, can become increasingly glycated with age or under hyperglycemic conditions [<xref ref-type="bibr" rid="b94-ad-8-3-334">94</xref>,<xref ref-type="bibr" rid="b95-ad-8-3-334">95</xref>], as also can ubiquitin [<xref ref-type="bibr" rid="b17-ad-8-3-334">17</xref>], are further complicating factors which will contribute to proteostatic decline [<xref ref-type="bibr" rid="b96-ad-8-3-334">96</xref>]. Thus, the developmentally-induced relative deficit of proteostatic capacity may well explain the increased vulnerability of adult organisms to age-related dysfunction, including accumulation of altered protein species, as well as increased PD risk. This condition would be further exacerbated should the homeostatic proteases and chaperone proteins themselves be inactivated by endogenous toxic agents such as MG. It is interesting to note that the naked mole-rat, a rodent which can live for over 30 years, unlike most rodents whose maximum lifespan is between 3 and 5 years, does not show an age-related decline in intracellular proteolytic activity [<xref ref-type="bibr" rid="b97-ad-8-3-334">97</xref>].</p>
<p>Changes in cytosolic proteolytic activity can also impact energy metabolism. The enzyme 6-phospho-2-kinase 2,6-bisphosphatase (Pfkfb3) generates fructose-2-6-bisphosphate; this enzyme is normally subject to continuous proteolytic degradation mediated by the ubiquitin/proteasome system, but if proteolysis of Pfkfb3 is inhibited, in neurones for example, glycolysis is stimulated and oxidative stress is increased, resulting in neurodegeneration [<xref ref-type="bibr" rid="b98-ad-8-3-334">98</xref>,<xref ref-type="bibr" rid="b99-ad-8-3-334">99</xref>]. Explanations of this phenomenon include decreased glutathione synthesis and increased MG formation due to the increased triose-phosphate generation [<xref ref-type="bibr" rid="b23-ad-8-3-334">23</xref>,<xref ref-type="bibr" rid="b100-ad-8-3-334">100</xref>]. Thus, the decline in the ubiquitin/proteasomal system, which characterises PD may also contribute to increased MG formation in the PD brain. Furthermore, in the substantia nigra increased MG generation would (as previously mentioned) following reaction with dopamine, increase the likelihood of formation of ADTIQ, which has been detected in diabetic brains, which in turn will damage mitochondria etc. and further exacerbate the condition, to promote a self-reinforcing deleterious cycle of dysfunction [<xref ref-type="bibr" rid="b70-ad-8-3-334">70</xref>,<xref ref-type="bibr" rid="b101-ad-8-3-334">101</xref>].</p>
<p>Changes in mitochondrial proteostasis could play a role in both PD and aging [<xref ref-type="bibr" rid="b87-ad-8-3-334">87</xref>,<xref ref-type="bibr" rid="b88-ad-8-3-334">88</xref>]. Again, developmental changes may impact on mitochondrial proteostatic function, especially should the rate or frequency of intra-mitochondrial protein synthesis decline as organism or organelle growth rate decreases. It has been clearly demonstrated that the Lon protease is partly responsible for the selective elimination of damaged proteins within mitochondria and whose expression is linked with mitogenesis. However, the activity of this protease has been shown to decline with age in a variety of model aging systems and the Lon protein is itself subject to oxidant-induced inactivation [<xref ref-type="bibr" rid="b102-ad-8-3-334">102</xref>,<xref ref-type="bibr" rid="b103-ad-8-3-334">103</xref>]. It has also been claimed that loss of mitochondrial proteolytic activity can have deleterious effects upon cytosolic proteasomal activity [<xref ref-type="bibr" rid="b104-ad-8-3-334">104</xref>,<xref ref-type="bibr" rid="b105-ad-8-3-334">105</xref>], thereby illustrating the interdependence of the components of the cellular proteostatic apparatus, although details of the mechanism responsible are not fully understood. Dysfunction or knock down of Hsc70-5/mortalin, which plays a role in mitogenesis and mitochondrial proteostasis, is lethal to dopamine-producing neurones in a Drosophila model of PD [<xref ref-type="bibr" rid="b106-ad-8-3-334">106</xref>]. A possible relationship between mitochondrial ribosome numbers and proteostasis is shown by the protein humanin, a putative translation product of mitochondrial 16S ribosomal RNA, which appears to suppress apoptosis, delay diabetes and inhibit amyloid-beta peptide toxicity [see 107 and refs therein].</p>
<p>It may be relevant to note in the bacterium <italic>Escherichia coli</italic> (bacteria being evolutionary precursors to mitochondria) it was found that organism growth rates strongly influenced constitutive ability to degrade aberrant polypeptide species in an exponential manner: constitutive proteolytic activity towards abnormal proteins approximately squared as growth rates doubled [<xref ref-type="bibr" rid="b108-ad-8-3-334">108</xref>], as do ribosome numbers. Should this relationship hold for eukaryotic cells in either or both the cytosolic and mitochondrial compartments, it follows that, as growth rates or mitogenesis decline as adult size is approached, maintenance of proteostasis will be strongly influenced by previous cellular history (i.e. protein synthesis rate) and the half-lives of the components of the proteostatic apparatus, thereby creating a delayed decline in proteolytic activity. Such a hysteresis-like phenomenon could help to explain (i) the extended latency of many age-related conditions, including PD, where altered proteins rarely accumulate during periods of rapid growth, but do so when growth has essentially ceased, and (ii) why increased aerobic activity which in turn induces mitogenesis is frequently beneficial by delaying age-related dysfunction.</p>
</sec>
<sec>
<title>Endogenous control of MG-mediated damage</title>
<p>It is argued above that MG may play important causal roles in both aging and PD, and that increased MG formation may occur as a consequence of chronic excessive glycolysis resulting from intake of high glycemic-index diets and/or compromised mitochondria-mediated ATP synthesis inducing a compensatory increased glycolytic flux to maintain ATP levels. In the event of increased MG formation, cells normally possess a defence apparatus, the glyoxalase system, which eliminates the reactive bicarbonyl converting it to d-lactate [see 28 for authoritative review]. However, it has been shown that glyoxalase activity declines with age [<xref ref-type="bibr" rid="b20-ad-8-3-334">20</xref>,<xref ref-type="bibr" rid="b109-ad-8-3-334">109</xref>], while lowered glyoxalase activity promotes mitochondrial dysfunction, accelerates aging and decreases lifespan in C. elegans, whereas upregulation is protective towards mitochondria and increases lifespan [<xref ref-type="bibr" rid="b64-ad-8-3-334">64</xref>]. Defects in the DJ-1 gene are known PD risk factors, and a member of the DJ-1 superfamily whose expression is controlled by DJ-1, has recently been shown to catalyse the deglycation of MG-modified proteins [<xref ref-type="bibr" rid="b58-ad-8-3-334">58</xref>].</p>
<p>Another possible and naturally-occurring protective agent may be the dipeptide carnosine (beta-alanyl-L-histidine). Not only can carnosine protect proteins against MG-mediated modification and inhibit the cross-linking of MG-modified protein with a normal polypeptide in model systems [<xref ref-type="bibr" rid="b110-ad-8-3-334">110</xref>,<xref ref-type="bibr" rid="b111-ad-8-3-334">111</xref>], but it can delay senescence in cultured cells [<xref ref-type="bibr" rid="b112-ad-8-3-334">112</xref>], and inhibit growth of tumour cells [<xref ref-type="bibr" rid="b113-ad-8-3-334">113</xref>] most likely by interfering with glycolysis [<xref ref-type="bibr" rid="b114-ad-8-3-334">114</xref>]. Other studies suggest that carnosine exerts anti-oxidant activity [<xref ref-type="bibr" rid="b115-ad-8-3-334">115</xref>,<xref ref-type="bibr" rid="b116-ad-8-3-334">116</xref>], chelates toxic metal ions [<xref ref-type="bibr" rid="b117-ad-8-3-334">117</xref>,<xref ref-type="bibr" rid="b118-ad-8-3-334">118</xref>] and is protective towards a number of reactive sugars and aldehydes such as glucose, fructose, ribose, malondialdehyde, acetaldehyde, formaldehyde, dihydroxyacetone [<xref ref-type="bibr" rid="b119-ad-8-3-334">119</xref>-<xref ref-type="bibr" rid="b122-ad-8-3-334">122</xref>] and 4-hydroxy-nonenal [<xref ref-type="bibr" rid="b123-ad-8-3-334">123</xref>]. By scavenging MG carnosine could also conceivably suppress generation of the neurotoxin ADTIQ [<xref ref-type="bibr" rid="b124-ad-8-3-334">124</xref>].</p>
<p>Carnosine is subject to degradation into its constituent amino acids by serum and cellular carnosinases, CNDP1 and CNDP2 respectively [<xref ref-type="bibr" rid="b125-ad-8-3-334">125</xref>-<xref ref-type="bibr" rid="b128-ad-8-3-334">128</xref>]. However, it is interesting to note that brain carnosinase activity increases with age [<xref ref-type="bibr" rid="b129-ad-8-3-334">129</xref>] while in PD brains overexpression of substantia nigra CNDP2 has been reported, compared to normal controls [<xref ref-type="bibr" rid="b130-ad-8-3-334">130</xref>].</p>
<p>Animal studies indicate that carnosine is beneficial towards senescence-accelerated mice [<xref ref-type="bibr" rid="b131-ad-8-3-334">131</xref>] and may have therapeutic potential where deleterious aldehydes such as MG appear to be important in age-related pathologies [<xref ref-type="bibr" rid="b132-ad-8-3-334">132</xref>] such as diabetes [<xref ref-type="bibr" rid="b127-ad-8-3-334">127</xref>,<xref ref-type="bibr" rid="b133-ad-8-3-334">133</xref>,<xref ref-type="bibr" rid="b134-ad-8-3-334">134</xref>], diabetic kidney disease [<xref ref-type="bibr" rid="b134-ad-8-3-334">134</xref>-<xref ref-type="bibr" rid="b136-ad-8-3-334">136</xref>], atherosclerosis [<xref ref-type="bibr" rid="b137-ad-8-3-334">137</xref>-<xref ref-type="bibr" rid="b139-ad-8-3-334">139</xref>] and cataractogenesis [<xref ref-type="bibr" rid="b140-ad-8-3-334">140</xref>-<xref ref-type="bibr" rid="b144-ad-8-3-334">144</xref>] as well as models of stroke [<xref ref-type="bibr" rid="b145-ad-8-3-334">145</xref>-<xref ref-type="bibr" rid="b148-ad-8-3-334">148</xref>], Alzheimer’s disease [<xref ref-type="bibr" rid="b149-ad-8-3-334">149</xref>-<xref ref-type="bibr" rid="b151-ad-8-3-334">151</xref>] and PD [<xref ref-type="bibr" rid="b152-ad-8-3-334">152</xref>-<xref ref-type="bibr" rid="b154-ad-8-3-334">154</xref>].</p>
<p>A number of double-blind, placebo-controlled dietary, supplementation studies have shown that carnosine improves aspects of brain function in human subjects. For example, behaviour was improved in autistic spectrum children [<xref ref-type="bibr" rid="b155-ad-8-3-334">155</xref>], cognition was improved in schizophrenic patients [<xref ref-type="bibr" rid="b156-ad-8-3-334">156</xref>], exercise performance and quality of life were improved in chronic heart disease patients [<xref ref-type="bibr" rid="b157-ad-8-3-334">157</xref>] and there was a significant improvement in cognition in Gulf war disease veterans [<xref ref-type="bibr" rid="b158-ad-8-3-334">158</xref>]; elderly patients fed carnosine plus the related peptide ansererine also showed improved cognition [<xref ref-type="bibr" rid="b159-ad-8-3-334">159</xref>]. These observations imply that the presence of serum carnosinase is not necessarily an impediment to carnosine’s potential efficacy, at least as far as the brain is concerned. Indeed, manipulation of cellular carnosine levels by either enhancing dipeptide synthesis or suppression of carnosinase activity could be fruitful areas of enquiry.</p>
</sec>
<sec>
<title>Concluding remarks</title>
<p>Homeostatic dysfunction (e.g. in proteostasis and mitochondrial maintenance) contributes causally to aging and related pathologies such as PD. Indeed, it has been shown that fibroblasts obtained from PD patients possess proteolytic and bioenergetic deficits [<xref ref-type="bibr" rid="b26-ad-8-3-334">26</xref>]. It is possible that mitochondrial dysfunction (of any origin) may result in increased glycolytic activity to compensate for the decline in ATP generation, which will in turn increase the potential for generation of the triose-phosphates glyceraldehyde-3-phosphate and dihydroxyacetone-phosphate and their decomposition product MG. Alternatively, excessive glycolytic activity, perhaps induced by high glycemic-index diets, may increase MG formation, especially in erythrocytes, which then, following secretion, promotes mitochondrial dysfunction in various tissues thereby creating a deleterious self-reinforcing cycle of dysfunction, especially if glyoxalase activity is insufficient to eliminate the increased MG formation. Consequently, the rates at which endogenous toxins, such as MG and its triose-phosphate precursors, as well as endogenous protective agents (e.g. glyoxalase and carnosine) are either generated or removed, need to be carefully regulated if organism viability is not to be compromised.</p>
<p>The degree of age-related vulnerability varies somewhat between tissues and individuals, most probably due to differences in development and metabolism, environmental effects, including diet and life-style choices, as well as genetic influences, otherwise we would all submit to the same age-related disease at the same time. And, as pointed out in the present piece, regulation of the common pathway for provision of energy and metabolic intermediates (i.e. glycolysis) and possibly the ingestion of glycated proteins, as well as any accompanying developmentally-related decrease in proteolytic activity, are important for maintenance of viability: homeostasis must be maintained to prevent accumulation of MG and other potential glycating agents (e.g. triose-phosphates) and their possible participation in the development of age-related disorders such as PD. (See <xref ref-type="table" rid="T1-ad-8-3-334">Table 1</xref> for concise summary).</p>
<table-wrap id="T1-ad-8-3-334" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Summary of factors which may either provoke or ameliorate age-related changes which contribute to Parkinson’s disease onset</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle">Possible common causal factors or processes to Parkinson’s disease and aging</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>Endogenous synthesis of methylglyoxal (MG): possible causes</underline>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Excessive glycolysis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  High glycemic index diet</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Inactivation of triose-phosphate isomerase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Decline of MG-scavenging or MG-eliminating processes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>Effects of MG include</underline>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Mitochondrial dysfunction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Proteostastic dysfunction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Protein cross-linking</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Protein AGEs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Formation of ADTIQ (neurotoxin)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>Increased intake and possible effects of dietary protein-AGEs</underline>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Reaction with RAGEs in gut wall</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Cell to cell transmission to CNS (??)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Induction of cognitive dysfunction (??)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>Possible ameliorative strategies towards aging and PD</underline>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Decreased glycolysis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Increased mitochondrial function</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Low glycemic index diet</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Increased intake or synthesis of carnosine (an anti-glycating/MG-scavenging agent).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Increased intake of leafy plant tissues containing anti-glycating/MG scavenging agents.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">   Raised glyoxalase activity.</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>This idea, in a more general sense, was most certainly better put, more than a quarter of a century ago, by the eminent cell-biologist and gerontologist Leonard Hayflick [<xref ref-type="bibr" rid="b160-ad-8-3-334">160</xref>], who made the following comments about aging and its causation. Hayflick wrote “Why do we age?” may be the wrong question. The right question may be “Why do we live as long as we do”? Hayflick also prefaced his piece by two quotations: “The constancy of the <italic>milieu interieur</italic> is the condition for a free life” - Claude Bernard” and “The inconstancy of the <italic>milieu interieur</italic> is the condition for the finitude of life - George Sacher”. Much recent research confirms Hayflick’s prescience. While there are many ways of “getting dead”, those processes which maintain homeostasis are likely to be important for delay of age-related pathology and aging generally.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-ad-8-3-334">
<label>1.</label>
<mixed-citation publication-type="journal"><name><surname>Ingram</surname><given-names>DK</given-names></name>, <name><surname>Roth</surname><given-names>GS</given-names></name> (<year>2011</year>). <article-title>Glycolytic inhibition as a strategy for developing calorie restriction mimetics</article-title>. <source/>Expt Gerontol, <volume>46</volume>: <fpage>148</fpage>-<lpage>154</lpage>.</mixed-citation>
</ref>
<ref id="b2-ad-8-3-334">
<label>2.</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name> (<year>2006</year>). <article-title>On the mechanisms of ageing suppression by dietary restriction - is persistent glycolysis the problem?</article-title>
<source/>Mech Ageing Dev, <volume>127</volume>: <fpage>8</fpage>-<lpage>15</lpage>.<pub-id pub-id-type="pmid">16274729</pub-id></mixed-citation>
</ref>
<ref id="b3-ad-8-3-334">
<label>3.</label>
<mixed-citation publication-type="journal"><name><surname>Fontana</surname><given-names>L</given-names></name>, <name><surname>Partridge</surname><given-names>L</given-names></name>, <name><surname>Longo</surname><given-names>VD</given-names></name> (<year>2010</year>). <article-title>Extending human life span - from yeast to humans</article-title>. <source/>Science, <volume>328</volume>: <fpage>321</fpage>-<lpage>326</lpage>.<pub-id pub-id-type="pmid">20395504</pub-id></mixed-citation>
</ref>
<ref id="b4-ad-8-3-334">
<label>4.</label>
<mixed-citation publication-type="journal"><name><surname>Anderson</surname><given-names>RM</given-names></name>, <name><surname>Weindruch</surname><given-names>R</given-names></name> (<year>2010</year>). <article-title>Metabolic reprogramming, caloric restriction and aging</article-title>. <source/>Trends Endocrinol Meta, <volume>21</volume>: <fpage>134</fpage>-<lpage>141</lpage>.</mixed-citation>
</ref>
<ref id="b5-ad-8-3-334">
<label>5.</label>
<mixed-citation publication-type="journal"><name><surname>Mattson</surname><given-names>MP</given-names></name>, <name><surname>Wan</surname><given-names>R</given-names></name> (<year>2005</year>). <article-title>Beneficial effects of intermittent feeding and caloric restriction on the cardiovascular and cerebrovascular systems</article-title>. <source/>J Nutr Biochem, <volume>18</volume>: <fpage>129</fpage>-<lpage>137</lpage>.</mixed-citation>
</ref>
<ref id="b6-ad-8-3-334">
<label>6.</label>
<mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>B</given-names></name>, <name><surname>Mattson</surname><given-names>MP</given-names></name>, <name><surname>Maudsley</surname><given-names>S</given-names></name> (<year>2006</year>). <article-title>Caloric restriction and intermittent feeding: two potential diets for successful brain aging</article-title>. <source/>Ageing Res Rev, <volume>5</volume>: <fpage>332</fpage>-<lpage>353</lpage>.<pub-id pub-id-type="pmid">16899414</pub-id></mixed-citation>
</ref>
<ref id="b7-ad-8-3-334">
<label>7.</label>
<mixed-citation publication-type="journal"><name><surname>Partidge</surname><given-names>L</given-names></name> (<year>2010</year>). <article-title>The new biology of aging</article-title>. <source/>Phil Trans R Soc B, <volume>365</volume>: <fpage>147</fpage>-<lpage>154</lpage>.<pub-id pub-id-type="pmid">20008392</pub-id></mixed-citation>
</ref>
<ref id="b8-ad-8-3-334">
<label>8.</label>
<mixed-citation publication-type="journal"><name><surname>Ralser</surname><given-names>M</given-names></name>, <name><surname>Warnelink</surname><given-names>MM</given-names></name>, <name><surname>Struys</surname><given-names>EA</given-names></name>, <etal>et al</etal> (<year>2008</year>). <article-title>A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth</article-title>. <source/>Proc Natl Acad Sci USA, <volume>105</volume>, <fpage>17807</fpage>-<lpage>11</lpage>.<pub-id pub-id-type="pmid">19004802</pub-id></mixed-citation>
</ref>
<ref id="b9-ad-8-3-334">
<label>9.</label>
<mixed-citation publication-type="journal"><name><surname>Dai</surname><given-names>DF</given-names></name>, <name><surname>Karunadharma</surname><given-names>PP</given-names></name>, <name><surname>Chiao</surname><given-names>YA</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart</article-title>. <source/>Aging Cell, <volume>13</volume>: <fpage>529</fpage>-<lpage>39</lpage>.<pub-id pub-id-type="pmid">24612461</pub-id></mixed-citation>
</ref>
<ref id="b10-ad-8-3-334">
<label>10.</label>
<mixed-citation publication-type="journal"><name><surname>Kapahi</surname><given-names>P</given-names></name>, <name><surname>Chen</surname><given-names>D</given-names></name>, <name><surname>Rogers</surname><given-names>AN</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging</article-title>. <source/>Cell Metab, <volume>11</volume>:<fpage>453</fpage>-<lpage>465</lpage>.<pub-id pub-id-type="pmid">20519118</pub-id></mixed-citation>
</ref>
<ref id="b11-ad-8-3-334">
<label>11.</label>
<mixed-citation publication-type="journal"><name><surname>Evans</surname><given-names>DS</given-names></name>, <name><surname>Kapahi</surname><given-names>P</given-names></name>, <name><surname>Hsueh</surname><given-names>W-C</given-names></name>, <name><surname>Kockel</surname><given-names>L</given-names></name> (<year>2010</year>). <article-title>TOR signalling never gets old: aging, longevity and TORC1 activity</article-title>. <source/>Aging Res Revs, <volume>10</volume>: <fpage>225</fpage>-<lpage>237</lpage></mixed-citation>
</ref>
<ref id="b12-ad-8-3-334">
<label>12.</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name> (<year>2010</year>). <article-title>NAD+ and metabolic regulation of age-related proteotoxicity: a possible role for methylglyoxal</article-title>. <source/>Exp Gerontol, <volume>45</volume>: <fpage>395</fpage>-<lpage>3099</lpage>.<pub-id pub-id-type="pmid">20226237</pub-id></mixed-citation>
</ref>
<ref id="b13-ad-8-3-334">
<label>13.</label>
<mixed-citation publication-type="journal"><name><surname>Desai</surname><given-names>KM</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name> (<year>2008</year>). <article-title>Free radical generation by methylglyoxal in tissues</article-title>. <source/>Drug Metab Drug Interact
<volume>23</volume>, <fpage>151</fpage>-<lpage>173</lpage>.</mixed-citation>
</ref>
<ref id="b14-ad-8-3-334">
<label>14.</label>
<mixed-citation publication-type="journal"><name><surname>Desai</surname><given-names>KM</given-names></name>, <name><surname>Chang</surname><given-names>T</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>Oxidative stress and aging: is methylglyoxal the hidden enemy?</article-title>
<source/>Can J Physiol Pharmacol, <volume>88</volume>: <fpage>273</fpage>-<lpage>284</lpage>.<pub-id pub-id-type="pmid">20393592</pub-id></mixed-citation>
</ref>
<ref id="b15-ad-8-3-334">
<label>15.</label>
<mixed-citation publication-type="journal"><name><surname>Semba</surname><given-names>RD</given-names></name>, <name><surname>Nicklett</surname><given-names>EJ</given-names></name>, <name><surname>Feerrucci</surname><given-names>L</given-names></name> (<year>2010</year>). <article-title>Does accumulation of advanced glycation end products contribute to the aging phenotype?</article-title>
<source/>J Gerontol (Med Sci), <volume>65A</volume>: <fpage>963</fpage>-<lpage>75</lpage>.</mixed-citation>
</ref>
<ref id="b16-ad-8-3-334">
<label>16.</label>
<mixed-citation publication-type="journal"><name><surname>Adolphe</surname><given-names>JL</given-names></name>, <name><surname>Drew</surname><given-names>MD</given-names></name>, <name><surname>Huang</surname><given-names>Q</given-names></name>, <name><surname>Silver</surname><given-names>TI</given-names></name>, <name><surname>Weber</surname><given-names>LP</given-names></name> (<year>2012</year>). <article-title>Postprandial impairment of flow-mediated dilation and elevated methylglyoxal after simple but not complex carbohydrate consumption</article-title>. <source/>Nutrit Res, <volume>32</volume>: <fpage>278</fpage>-<lpage>284</lpage>.<pub-id pub-id-type="pmid">22575041</pub-id></mixed-citation>
</ref>
<ref id="b17-ad-8-3-334">
<label>17.</label>
<mixed-citation publication-type="journal"><name><surname>Uchiki</surname><given-names>T</given-names></name>, <name><surname>Weikel</surname><given-names>KA</given-names></name>, <name><surname>Jiao</surname><given-names>W</given-names></name>, <name><surname>Shang</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease(in nondiabetics)</article-title>. <source/>Aging Cell, <volume>11</volume>: <fpage>1</fpage>-<lpage>13</lpage>.<pub-id pub-id-type="pmid">21967227</pub-id></mixed-citation>
</ref>
<ref id="b18-ad-8-3-334">
<label>18.</label>
<mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>N</given-names></name>, <name><surname>Thornalley</surname><given-names>PJ</given-names></name> (<year>2007</year>). <article-title>Advanced glycation endproducts: what is their relevance to diabetic complications?</article-title>
<source/>Diabetes Obes Metab, <volume>9</volume>: <fpage>233</fpage>-<lpage>245</lpage>.<pub-id pub-id-type="pmid">17391149</pub-id></mixed-citation>
</ref>
<ref id="b19-ad-8-3-334">
<label>19.</label>
<mixed-citation publication-type="journal"><name><surname>Dhar</surname><given-names>I</given-names></name>, <name><surname>Dhar</surname><given-names>A</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>Desa</surname><given-names>KM</given-names></name> (<year>2013</year>). <article-title>Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose-fed Sprague- Dawley rats</article-title>. <source/>PLoS One, <volume>8</volume>(<issue>9</issue>) <fpage>e74212</fpage><pub-id pub-id-type="pmid">24040205</pub-id></mixed-citation>
</ref>
<ref id="b20-ad-8-3-334">
<label>20.</label>
<mixed-citation publication-type="journal"><name><surname>Fleming</surname><given-names>T</given-names></name>, <name><surname>Cuny</surname><given-names>T</given-names></name>, <name><surname>Nawroth</surname><given-names>G</given-names></name>, <name><surname>Djuric</surname><given-names>Z</given-names></name>
<etal>et al</etal> (<year>2012</year>). <article-title>Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?</article-title>
<source/>Diabetologia, <volume>55</volume>: <fpage>1151</fpage>-<lpage>1155</lpage>.<pub-id pub-id-type="pmid">22270223</pub-id></mixed-citation>
</ref>
<ref id="b21-ad-8-3-334">
<label>21.</label>
<mixed-citation publication-type="journal"><name><surname>Beisswenger</surname><given-names>PJ</given-names></name>, <name><surname>Howell</surname><given-names>SK</given-names></name>, <name><surname>Smith</surname><given-names>K</given-names></name>, <name><surname>Szwergold</surname><given-names>BS</given-names></name> (<year>2003</year>). <article-title>Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methyglyoxal levels in diabetes</article-title>. <source/>Biochim Biophys Acta, <volume>1637</volume>: <fpage>98</fpage>-<lpage>106</lpage>.<pub-id pub-id-type="pmid">12527413</pub-id></mixed-citation>
</ref>
<ref id="b22-ad-8-3-334">
<label>22.</label>
<mixed-citation publication-type="journal"><name><surname>Gracy</surname><given-names>RW</given-names></name>, <name><surname>Talent</surname><given-names>JM</given-names></name>, <name><surname>Zvaigze</surname><given-names>AL</given-names></name> (<year>1998</year>). <article-title>Molecular wear and tear leads to a terminal marking and the unstable isoforms of aging</article-title>. <source/>Expt J Zool, <volume>282</volume>: <fpage>18</fpage>-<lpage>27</lpage>.</mixed-citation>
</ref>
<ref id="b23-ad-8-3-334">
<label>23.</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name> (<year>2011</year>). <article-title>Energy metabolism and ageing regulation: metabolically driven deamidation of triosephosphate isomerase may contribute to proteostatic dysfunction</article-title>. <source/>Ageing Res Revs, <volume>10</volume>: <fpage>498</fpage>-<lpage>502</lpage>.<pub-id pub-id-type="pmid">21651995</pub-id></mixed-citation>
</ref>
<ref id="b24-ad-8-3-334">
<label>24.</label>
<mixed-citation publication-type="journal"><name><surname>Kalapos</surname><given-names>MP</given-names></name> (<year>2013</year>). <article-title>Where does plasma methylglyoxal originate from?</article-title>
<source/>Diabetes Res Clin Pract, <volume>99</volume>: <fpage>260</fpage>-<lpage>71</lpage>.<pub-id pub-id-type="pmid">23206674</pub-id></mixed-citation>
</ref>
<ref id="b25-ad-8-3-334">
<label>25.</label>
<mixed-citation publication-type="journal"><name><surname>Newsholme</surname><given-names>EA</given-names></name>, <name><surname>Start</surname><given-names>C</given-names></name>. <source/>In Regulation in Metabolism, pp<fpage>99</fpage>, John Wiley and Sons, London <year>1973</year>.</mixed-citation>
</ref>
<ref id="b26-ad-8-3-334">
<label>26.</label>
<mixed-citation publication-type="journal"><name><surname>Ambrosi</surname><given-names>G</given-names></name>, <name><surname>Ghezzi</surname><given-names>C</given-names></name>, <name><surname>Sepe</surname><given-names>S</given-names></name>, <name><surname>Milanese</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson’s disease</article-title>. <source/>Biochim Biophys Acta, <volume>1842</volume>: <fpage>1385</fpage>-<lpage>1394</lpage>.<pub-id pub-id-type="pmid">24854107</pub-id></mixed-citation>
</ref>
<ref id="b27-ad-8-3-334">
<label>27.</label>
<mixed-citation publication-type="journal"><name><surname>Kalapos</surname><given-names>MP</given-names></name> (<year>1999</year>). <article-title>Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications</article-title>. <source/>Toxicol Letts, <volume>110</volume>: <fpage>145</fpage>-<lpage>175</lpage>.<pub-id pub-id-type="pmid">10597025</pub-id></mixed-citation>
</ref>
<ref id="b28-ad-8-3-334">
<label>28.</label>
<mixed-citation publication-type="journal"><name><surname>Rabbini</surname><given-names>N</given-names></name>, <name><surname>Thornalley</surname><given-names>PJ</given-names></name> (<year>2012</year>). <article-title>Methylglyoxal, glyoxalase-1 and the dicarbonyl proteome</article-title>. <source/>Amino Acids, <volume>42</volume>:<fpage>1133</fpage>-<lpage>42</lpage>.<pub-id pub-id-type="pmid">20963454</pub-id></mixed-citation>
</ref>
<ref id="b29-ad-8-3-334">
<label>29.</label>
<mixed-citation publication-type="journal"><name><surname>Untereiner</surname><given-names>AA</given-names></name>, <name><surname>Dhar</surname><given-names>A</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name> (<year>2011</year>). <article-title>Increased renal methylglyoxal formation with down-regulation of PGC-1α-FBPase pathway in cystathione-γ-lyase knockout mice</article-title>. <source/>PLoS ONE, <volume>6</volume>, <fpage>e29592</fpage><pub-id pub-id-type="pmid">22216325</pub-id></mixed-citation>
</ref>
<ref id="b30-ad-8-3-334">
<label>30.</label>
<mixed-citation publication-type="journal"><name><surname>Auburger</surname><given-names>G</given-names></name>, <name><surname>Kurz</surname><given-names>A</given-names></name> (<year>2011</year>). <article-title>The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety and Parkinson’s disease</article-title>. <source/>Aging 3:
<fpage>5</fpage>-<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="b31-ad-8-3-334">
<label>31.</label>
<mixed-citation publication-type="journal"><name><surname>Munch</surname><given-names>G</given-names></name>, <name><surname>Westcott</surname><given-names>B</given-names></name>, <name><surname>Menini</surname><given-names>T</given-names></name>, <name><surname>Gugliucci</surname><given-names>A</given-names></name> (<year>2012</year>). <article-title>Advanced glycation endproducts and their pathogenic roles in neurological disorders</article-title>. <source/>Amino Acids, <volume>42</volume>: <fpage>1221</fpage>-<lpage>1226</lpage>.<pub-id pub-id-type="pmid">20949363</pub-id></mixed-citation>
</ref>
<ref id="b32-ad-8-3-334">
<label>32.</label>
<mixed-citation publication-type="journal"><name><surname>Chondrogianni</surname><given-names>N</given-names></name>, <name><surname>Petropoulos</surname><given-names>I</given-names></name>, <name><surname>Grimm</surname><given-names>S</given-names></name>, <name><surname>Georgila</surname><given-names>K</given-names></name>, <name><surname>Catalgol</surname><given-names>B</given-names></name>, <name><surname>Friguet</surname><given-names>B</given-names></name>, <name><surname>Grune</surname><given-names>T</given-names></name>, <name><surname>Gonos</surname><given-names>ES</given-names></name> (<year>2014</year>). <article-title>Protein damage, repair and proteolysis</article-title>. <source/>Mol Aspects Med, <volume>35</volume>:<fpage>1</fpage>-<lpage>71</lpage><pub-id pub-id-type="pmid">23107776</pub-id></mixed-citation>
</ref>
<ref id="b33-ad-8-3-334">
<label>33.</label>
<mixed-citation publication-type="journal"><name><surname>Rabbani</surname><given-names>N</given-names></name>, <name><surname>Shaheen</surname><given-names>F</given-names></name>, <name><surname>Anwar</surname><given-names>A</given-names></name>, <name><surname>Masania</surname><given-names>J</given-names></name>, <name><surname>Thornalley</surname><given-names>PJ</given-names></name> (<year>2014</year>). <article-title>Assay of methylglyoxal-derived protein and nucleotide AGEs</article-title>. <source/>Biochem Soc Trans, <volume>42</volume>: <fpage>511</fpage>-<lpage>517</lpage>.<pub-id pub-id-type="pmid">24646270</pub-id></mixed-citation>
</ref>
<ref id="b34-ad-8-3-334">
<label>34.</label>
<mixed-citation publication-type="journal"><name><surname>Queisser</surname><given-names>MA</given-names></name>, <name><surname>Yao</surname><given-names>D</given-names></name>, <name><surname>Geisler</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Hyperglycemia impairs proteasome function by methylglyoxal</article-title>. <source/>Diabetes, <volume>59</volume>: <fpage>670</fpage>-<lpage>678</lpage><pub-id pub-id-type="pmid">20009088</pub-id></mixed-citation>
</ref>
<ref id="b35-ad-8-3-334">
<label>35.</label>
<mixed-citation publication-type="journal"><name><surname>Moheimani</surname><given-names>F</given-names></name>, <name><surname>Morgan</surname><given-names>PE</given-names></name>, <name><surname>van Reyk</surname><given-names>DM</given-names></name>, <name><surname>Davies</surname><given-names>MJ</given-names></name> (<year>2010</year>). <article-title>Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis</article-title>. <source/>Biochim Biophys Acta, <volume>1802</volume>: <fpage>561</fpage>-<lpage>571</lpage>.<pub-id pub-id-type="pmid">20176104</pub-id></mixed-citation>
</ref>
<ref id="b36-ad-8-3-334">
<label>36.</label>
<mixed-citation publication-type="journal"><name><surname>Bento</surname><given-names>CF</given-names></name>, <name><surname>Marques</surname><given-names>F</given-names></name>, <name><surname>Fernandez</surname><given-names>R</given-names></name>, <name><surname>Pereira</surname><given-names>P</given-names></name> (<year>2010</year>). <article-title>Methylglyoxal alters the function and stability of critical components of the protein quality control</article-title>. <source/>PLoS One, <volume>5</volume>, <fpage>e13007</fpage>.<pub-id pub-id-type="pmid">20885985</pub-id></mixed-citation>
</ref>
<ref id="b37-ad-8-3-334">
<label>37.</label>
<mixed-citation publication-type="journal"><name><surname>SinhaRoy</surname><given-names>S</given-names></name>, <name><surname>Banerjee</surname><given-names>S</given-names></name>, <name><surname>Ray</surname><given-names>M</given-names></name>, <name><surname>Ray</surname><given-names>S</given-names></name> (<year>2005</year>). <article-title>Possible involvement of glutamic and/or aspartic residue(s) and requirement of mitochondrial integrity for the protective effect of creatine against inhibition of cardiac mitochondrial respiration by methyglyoxal</article-title>. <source/>Mol Cell Biochem, <volume>271</volume>: <fpage>167</fpage>-<lpage>176</lpage>.<pub-id pub-id-type="pmid">15881668</pub-id></mixed-citation>
</ref>
<ref id="b38-ad-8-3-334">
<label>38.</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name> (<year>2009</year>). <article-title>Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells</article-title>. <source/>Biochem Pharmacol, <volume>77</volume>: <fpage>1709</fpage>-<lpage>1715</lpage>.<pub-id pub-id-type="pmid">19428325</pub-id></mixed-citation>
</ref>
<ref id="b39-ad-8-3-334">
<label>39.</label>
<mixed-citation publication-type="journal"><name><surname>Campello</surname><given-names>L</given-names></name>, <name><surname>Esteve-Rudd</surname><given-names>J</given-names></name>, <name><surname>Bru-Martinez</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian MPTP-treated monkeys</article-title>. <source/>PLoS One, <volume>8</volume>(<issue>9</issue>) <fpage>e74439</fpage>.<pub-id pub-id-type="pmid">24040246</pub-id></mixed-citation>
</ref>
<ref id="b40-ad-8-3-334">
<label>40.</label>
<mixed-citation publication-type="journal"><name><surname>Gomez</surname><given-names>A</given-names></name>, <name><surname>Ferrer</surname><given-names>I</given-names></name> (<year>2009</year>). <article-title>Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body disease</article-title>. <source/>J Neurosci Res, <volume>87</volume>: <fpage>1002</fpage>-<lpage>1013</lpage>.<pub-id pub-id-type="pmid">18855937</pub-id></mixed-citation>
</ref>
<ref id="b41-ad-8-3-334">
<label>41.</label>
<mixed-citation publication-type="journal"><name><surname>Dunn</surname><given-names>L</given-names></name>, <name><surname>Allen</surname><given-names>Gfg</given-names></name>, <name><surname>Mamais</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Dysregulation of glucose metabolism is an early event in sporadic Parkinson disease</article-title>. <source/>Neurobiol Aging, <volume>35</volume>, <fpage>1111</fpage>-<lpage>1115</lpage>.<pub-id pub-id-type="pmid">24300239</pub-id></mixed-citation>
</ref>
<ref id="b42-ad-8-3-334">
<label>42.</label>
<mixed-citation publication-type="journal"><name><surname>Murakami</surname><given-names>K</given-names></name>, <name><surname>Miyake</surname><given-names>Y</given-names></name>, <name><surname>Sasaki</surname><given-names>S</given-names></name>, <name><surname>Tanaka</surname><given-names>K</given-names></name>. <etal>et al</etal> (<year>2010</year>). <article-title>Dietary glycemic index is inversely associated with the risk of Parkinson’s disease: a case-control study in Japan</article-title>. <source/>Nutrition, <volume>26</volume>: <fpage>515</fpage>-<lpage>521</lpage>.<pub-id pub-id-type="pmid">19628370</pub-id></mixed-citation>
</ref>
<ref id="b43-ad-8-3-334">
<label>43.</label>
<mixed-citation publication-type="journal"><name><surname>Okubo</surname><given-names>H</given-names></name>, <name><surname>Miyake</surname><given-names>Y</given-names></name>, <name><surname>Sasaki</surname><given-names>S</given-names></name>, <name><surname>Murakami</surname><given-names>K</given-names></name>. <etal>et al</etal> (<year>2012</year>). <article-title>Dietary patterns and risk of Parkinson's disease: a case-control study in Japan</article-title>. <source/>Eur J Neurol, <volume>19</volume>: <fpage>681</fpage>-<lpage>688</lpage>.<pub-id pub-id-type="pmid">22136555</pub-id></mixed-citation>
</ref>
<ref id="b44-ad-8-3-334">
<label>44.</label>
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Cheng</surname><given-names>B</given-names></name> (<year>2010</year>). <article-title>Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity</article-title>. <source/>J Mol Neurosci, <volume>42</volume>:<fpage>145</fpage>-<lpage>153</lpage>.<pub-id pub-id-type="pmid">20333481</pub-id></mixed-citation>
</ref>
<ref id="b45-ad-8-3-334">
<label>45.</label>
<mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>B</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>An</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Ketogenic diet protects dopaminergic neurones against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson’s disease</article-title>. <source/>Brain Res, <volume>1286</volume>: <fpage>25</fpage>-<lpage>31</lpage>.<pub-id pub-id-type="pmid">19559687</pub-id></mixed-citation>
</ref>
<ref id="b46-ad-8-3-334">
<label>46.</label>
<mixed-citation publication-type="journal"><name><surname>Stafstrom</surname><given-names>CE</given-names></name>, <name><surname>Rho</surname><given-names>JM</given-names></name> (<year>2012</year>). <article-title>The ketogenic diet as a treatment paradigm for diverse neurological disorders</article-title>. <source/>Front Pharmacol, <volume>3</volume>: <fpage>59</fpage><pub-id pub-id-type="pmid">22509165</pub-id></mixed-citation>
</ref>
<ref id="b47-ad-8-3-334">
<label>47.</label>
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Lin</surname><given-names>M</given-names></name>, <name><surname>Wu</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>. <etal>et al</etal> (<year>2011</year>). <article-title>Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect</article-title>. <source/>Proc Natl Acad Sci USA, <volume>108</volume>:<fpage>16259</fpage>-<lpage>64</lpage>.<pub-id pub-id-type="pmid">21930938</pub-id></mixed-citation>
</ref>
<ref id="b48-ad-8-3-334">
<label>48.</label>
<mixed-citation publication-type="journal"><name><surname>Ferrer</surname><given-names>I</given-names></name>, <name><surname>Martinez</surname><given-names>A</given-names></name>, <name><surname>Bianco</surname><given-names>R</given-names></name>, <name><surname>Dalto</surname><given-names>E</given-names></name>, <name><surname>Carmona</surname><given-names>M</given-names></name> (<year>2011</year>). <article-title>Neuropathology of sporadic Parkinson’s disease before the appearance of parkinsonianism: preclinical Parkinson’s disease</article-title>. <source/>J Neural Transm, <volume>118</volume>: <fpage>821</fpage>-<lpage>839</lpage>.<pub-id pub-id-type="pmid">20862500</pub-id></mixed-citation>
</ref>
<ref id="b49-ad-8-3-334">
<label>49.</label>
<mixed-citation publication-type="journal"><name><surname>Vincent</surname><given-names>A</given-names></name>, <name><surname>Briggs</surname><given-names>L</given-names></name>, <name><surname>Chatwin</surname><given-names>GFJ</given-names></name>, <name><surname>Emery</surname><given-names>E</given-names></name>. <etal>et al</etal> (<year>2012</year>). <article-title>Parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress</article-title>. <source/>Human Mol Gen, <volume>21</volume>: <fpage>1760</fpage>-<lpage>1769</lpage>.</mixed-citation>
</ref>
<ref id="b50-ad-8-3-334">
<label>50.</label>
<mixed-citation publication-type="journal"><name><surname>Davison</surname><given-names>EJ</given-names></name>, <name><surname>Pennington</surname><given-names>K</given-names></name>, <name><surname>Hung</surname><given-names>CC</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function</article-title>. <source/>Proteomics, <volume>9</volume>: <fpage>4284</fpage>-<lpage>4297</lpage>.<pub-id pub-id-type="pmid">19725078</pub-id></mixed-citation>
</ref>
<ref id="b51-ad-8-3-334">
<label>51.</label>
<mixed-citation publication-type="journal"><name><surname>Requejo-Aguilar</surname><given-names>R</given-names></name>, <name><surname>Lopez-Fabuel</surname><given-names>I</given-names></name>, <name><surname>Fernandez</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>PINK-1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1</article-title>. <source/>Nat Commun, <day>24</day>:<volume>5</volume>:<fpage>4514</fpage>.<pub-id pub-id-type="pmid">25058378</pub-id></mixed-citation>
</ref>
<ref id="b52-ad-8-3-334">
<label>52.</label>
<mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Teng</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>B</given-names></name>, <name><surname>Xie</surname><given-names>A</given-names></name>. (<year>2014</year>). <article-title>Association of RAGE gene polymorphisms with sporadic Parkinson's disease in Chinese Han population</article-title>. <source/>Neurosci Lett, <volume>559</volume>:<fpage>158</fpage>-<lpage>62</lpage>.<pub-id pub-id-type="pmid">24304868</pub-id></mixed-citation>
</ref>
<ref id="b53-ad-8-3-334">
<label>53.</label>
<mixed-citation publication-type="journal"><name><surname>Vincente Miranda</surname><given-names>H</given-names></name>, <name><surname>El-Agnaf</surname><given-names>OM</given-names></name>, <name><surname>Outeiro</surname><given-names>TF</given-names></name> (<year>2016</year>). <article-title>Glycation in Parkinson’s disease and Alzheimer’s disease</article-title>. <source/>Mov Disord, <volume>31</volume>: <fpage>782</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="pmid">26946341</pub-id></mixed-citation>
</ref>
<ref id="b54-ad-8-3-334">
<label>54.</label>
<mixed-citation publication-type="journal"><name><surname>Cereda</surname><given-names>E</given-names></name>, <name><surname>Barichella</surname><given-names>M</given-names></name>, <name><surname>Cassani</surname><given-names>E</given-names></name>, <name><surname>Caccialanza</surname><given-names>R</given-names></name>, <name><surname>Pezzoli</surname><given-names>G</given-names></name> (<year>2012</year>). <article-title>Clinical features of Parkinson disease when onset of diabetes came first: A case-control study</article-title>. <source/>Neurology, <volume>78</volume>: <fpage>1507</fpage>-<lpage>1511</lpage><pub-id pub-id-type="pmid">22539572</pub-id></mixed-citation>
</ref>
<ref id="b55-ad-8-3-334">
<label>55.</label>
<mixed-citation publication-type="journal"><name><surname>Kurz</surname><given-names>A</given-names></name>, <name><surname>Rabbani</surname><given-names>N</given-names></name>, <name><surname>Walter</surname><given-names>M</given-names></name>, <name><surname>Thornalley</surname><given-names>P</given-names></name>. <etal>et al</etal> (<year>2011</year>). <article-title>α-Synuclein deficiency leads to increased glyoxalase 1 expression and glycation stress</article-title>. <source/>Cell Mol Life Sci, <volume>68</volume>: <fpage>721</fpage>-<lpage>733</lpage>.<pub-id pub-id-type="pmid">20711648</pub-id></mixed-citation>
</ref>
<ref id="b56-ad-8-3-334">
<label>56.</label>
<mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>SY</given-names></name>, <name><surname>Lu</surname><given-names>SY</given-names></name>, <name><surname>Sivasubramaniyam</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice</article-title>. <source/>Nat Commun, <day>16</day>;<volume>6</volume>:<fpage>7415</fpage>.<pub-id pub-id-type="pmid">26077864</pub-id></mixed-citation>
</ref>
<ref id="b57-ad-8-3-334">
<label>57.</label>
<mixed-citation publication-type="journal"><name><surname>Requejo-Aguilar</surname><given-names>R</given-names></name>, <name><surname>Lopez-Fabuel</surname><given-names>I</given-names></name>, <name><surname>Jimenez-Blasco</surname><given-names>D</given-names></name>, <name><surname>Fernandez</surname><given-names>E</given-names></name>, <name><surname>Almeida</surname><given-names>A</given-names></name>, <name><surname>Bolaños</surname><given-names>JP</given-names></name> (<year>2015</year>). <article-title>DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating Pink1</article-title>. <source/>Biochem J, <volume>467</volume>: <fpage>303</fpage>-<lpage>10</lpage>.<pub-id pub-id-type="pmid">25670069</pub-id></mixed-citation>
</ref>
<ref id="b58-ad-8-3-334">
<label>58.</label>
<mixed-citation publication-type="journal"><name><surname>Mihoub</surname><given-names>M</given-names></name>, <name><surname>Abdallah</surname><given-names>J</given-names></name>, <name><surname>Gontero</surname><given-names>B</given-names></name>, <name><surname>Dairou</surname><given-names>J</given-names></name>, <name><surname>Richarme</surname><given-names>G</given-names></name> (<year>2015</year>). <article-title>The DJ-1 superfamily member Hsp31 repairs proteins from glycation by methylglyoxal and glyoxal</article-title>. <source/>Biochem Biophys Res Commun, <volume>463</volume>: <fpage>1305</fpage>-<lpage>10</lpage>.<pub-id pub-id-type="pmid">26102038</pub-id></mixed-citation>
</ref>
<ref id="b59-ad-8-3-334">
<label>59.</label>
<mixed-citation publication-type="journal"><name><surname>Im</surname><given-names>JY</given-names></name>, <name><surname>Lee</surname><given-names>KW</given-names></name>, <name><surname>Woo</surname><given-names>JM</given-names></name>, <name><surname>Junn</surname><given-names>E</given-names></name>, <name><surname>Mouradian</surname><given-names>MM</given-names></name> (<year>2012</year>). <article-title>DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway</article-title>. <source/>Hum Mol Gen, <volume>21</volume>: <fpage>3013</fpage>-<lpage>3024</lpage>.<pub-id pub-id-type="pmid">22492997</pub-id></mixed-citation>
</ref>
<ref id="b60-ad-8-3-334">
<label>60.</label>
<mixed-citation publication-type="journal"><name><surname>Xue</surname><given-names>M</given-names></name>, <name><surname>Rabbani</surname><given-names>N</given-names></name>, <name><surname>Momiji</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Transcriptional control of glyoxalase-1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation</article-title>. <source/>Biochem J, <volume>443</volume>: <fpage>213</fpage>-<lpage>222</lpage><pub-id pub-id-type="pmid">22188542</pub-id></mixed-citation>
</ref>
<ref id="b61-ad-8-3-334">
<label>61.</label>
<mixed-citation publication-type="journal"><name><surname>Piec</surname><given-names>I</given-names></name>, <name><surname>Listrat</surname><given-names>A</given-names></name>, <name><surname>Alliot</surname><given-names>J</given-names></name>, <name><surname>Chambon</surname><given-names>C</given-names></name>, <name><surname>Taylor</surname><given-names>RG</given-names></name>, <name><surname>Bechet</surname><given-names>D</given-names></name> (<year>2005</year>). <article-title>Differential proteome analysis of aging in rat skeletal muscle</article-title>. <source/>FASEB J, <volume>19</volume>:<fpage>1143</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="pmid">15831715</pub-id></mixed-citation>
</ref>
<ref id="b62-ad-8-3-334">
<label>62.</label>
<mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>EK</given-names></name>, <name><surname>Rogowska-Wrzesinska</surname><given-names>A</given-names></name>, <name><surname>Roepstorf</surname><given-names>P</given-names></name>, <name><surname>Bulteau</surname><given-names>AM</given-names></name>, <name><surname>Friguet</surname><given-names>B</given-names></name> (<year>2010</year>). <article-title>Protein modification and replicative senescence of WI-38 human embryonic fibroblasts</article-title>. <source/>Aging Cell, <volume>9</volume>: <fpage>252</fpage>-<lpage>2725</lpage>.<pub-id pub-id-type="pmid">20102351</pub-id></mixed-citation>
</ref>
<ref id="b63-ad-8-3-334">
<label>63.</label>
<mixed-citation publication-type="journal"><name><surname>Kuhla</surname><given-names>B</given-names></name>, <name><surname>Boeck</surname><given-names>K</given-names></name>, <name><surname>Luth</surname><given-names>HJ</given-names></name>, <name><surname>Schmidt</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2006</year>). <article-title>Age-dependent changes of glyoxalase expression in human brain</article-title>. <source/>Neurobiol Aging, <volume>27</volume>: <fpage>815</fpage>-<lpage>822</lpage><pub-id pub-id-type="pmid">15950319</pub-id></mixed-citation>
</ref>
<ref id="b64-ad-8-3-334">
<label>64.</label>
<mixed-citation publication-type="journal"><name><surname>Morcos</surname><given-names>M</given-names></name>, <name><surname>Du</surname><given-names>X</given-names></name>, <name><surname>Pfisterer</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2008</year>). <article-title>Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in C. elegans</article-title>. <source/>Aging Cell, <volume>7</volume>: <fpage>260</fpage>-<lpage>269</lpage>.<pub-id pub-id-type="pmid">18221415</pub-id></mixed-citation>
</ref>
<ref id="b65-ad-8-3-334">
<label>65.</label>
<mixed-citation publication-type="journal"><name><surname>Pun</surname><given-names>PB</given-names></name>, <name><surname>Murphy</surname><given-names>MP</given-names></name> (<year>2012</year>). <article-title>Pathological Significance of Mitochondrial Glycation</article-title>. <source/>Int J Cell Biol, <volume>2012</volume>: <fpage>843505</fpage>.<pub-id pub-id-type="pmid">22778743</pub-id></mixed-citation>
</ref>
<ref id="b66-ad-8-3-334">
<label>66.</label>
<mixed-citation publication-type="journal"><name><surname>Tatone</surname><given-names>C</given-names></name>, <name><surname>Heizenrieder</surname><given-names>T</given-names></name>, <name><surname>Di Emidio</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Evidence that carbonyl stress by methylglyoxal exposure induces DNA damage and spindle aberrations, affects mitochondrial integrity in mammalian oocytes and contributes to oocyte ageing</article-title>. <source/>Hum Reprod, <volume>26</volume>:<fpage>1843</fpage>-<lpage>1859</lpage>.<pub-id pub-id-type="pmid">21558076</pub-id></mixed-citation>
</ref>
<ref id="b67-ad-8-3-334">
<label>67.</label>
<mixed-citation publication-type="journal"><name><surname>Beeri</surname><given-names>MS</given-names></name>, <name><surname>Moshier</surname><given-names>E</given-names></name>, <name><surname>Schmeidler</surname><given-names>J</given-names></name>, <name><surname>Godbold</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals</article-title>. <source/>Mech Ageing Dev, <volume>132</volume>: <fpage>583</fpage>-<lpage>587</lpage>.<pub-id pub-id-type="pmid">22079406</pub-id></mixed-citation>
</ref>
<ref id="b68-ad-8-3-334">
<label>68.</label>
<mixed-citation publication-type="journal"><name><surname>Szent-Gyorgyi</surname><given-names>A</given-names></name>, <name><surname>McLaughlin</surname><given-names>JA</given-names></name> (<year>1975</year>). <article-title>Interaction of glyoxal and methylglyoxal and biogenic amines</article-title>. <source/>Proc Natl Acad Sci USA, <volume>72</volume>:<fpage>1610</fpage>-<lpage>1611</lpage>.<pub-id pub-id-type="pmid">236562</pub-id></mixed-citation>
</ref>
<ref id="b69-ad-8-3-334">
<label>69.</label>
<mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Occurrence and distribution of a salsolinol-like compound, 1-acetyl-6.7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in Parkinsonian brains</article-title>. <source/>J Neural Transm, <volume>119</volume>: <fpage>435</fpage>-<lpage>441</lpage>.<pub-id pub-id-type="pmid">22065205</pub-id></mixed-citation>
</ref>
<ref id="b70-ad-8-3-334">
<label>70.</label>
<mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>DW</given-names></name>, <name><surname>Xin</surname><given-names>N</given-names></name>, <name><surname>Xie</surname><given-names>BJ</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes</article-title>. <source/>Int J Mol Med, <volume>33</volume>: <fpage>736</fpage>-<lpage>742</lpage>.<pub-id pub-id-type="pmid">24366308</pub-id></mixed-citation>
</ref>
<ref id="b71-ad-8-3-334">
<label>71.</label>
<mixed-citation publication-type="journal"><name><surname>Bonnet</surname><given-names>R</given-names></name>, <name><surname>Pavlovic</surname><given-names>S</given-names></name>, <name><surname>Lehmann</surname><given-names>J</given-names></name>, <name><surname>Rommelspacher</surname><given-names>H</given-names></name> (<year>2004</year>). <article-title>The strong inhibition of triose-phosphate isomerase by the natural beta-carbolines may explain their neurotoxic actions</article-title>. <source/>Neurosci, <volume>127</volume>: <fpage>443</fpage>-<lpage>453</lpage>.</mixed-citation>
</ref>
<ref id="b72-ad-8-3-334">
<label>72.</label>
<mixed-citation publication-type="journal"><name><surname>Tajes</surname><given-names>M</given-names></name>, <name><surname>Eraso-Pichot</surname><given-names>A</given-names></name>, <name><surname>Rubio-Moscardo</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Methylglyoxal reduces mitochondrial potential and activates Bax and caspase-3 in neurons: implications for Alzheimer’s disease</article-title>. <source/>Neurosci Lett, <volume>580</volume>:<fpage>78</fpage>-<lpage>82</lpage><pub-id pub-id-type="pmid">25102327</pub-id></mixed-citation>
</ref>
<ref id="b73-ad-8-3-334">
<label>73.</label>
<mixed-citation publication-type="journal"><name><surname>Tajes</surname><given-names>M</given-names></name>, <name><surname>Eraso-Pichot</surname><given-names>A</given-names></name>, <name><surname>Rubio-Moscardo</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Methylglyoxal produced by amyloid-B peptide-induced nitrotyrosination of triosephosphate isomerase triggers neuronal death in Alzheimer’s disease</article-title>. <source/>J Alzheimer’s Dis, <volume>41</volume>: <fpage>273</fpage>-<lpage>288</lpage>.<pub-id pub-id-type="pmid">24614897</pub-id></mixed-citation>
</ref>
<ref id="b74-ad-8-3-334">
<label>74.</label>
<mixed-citation publication-type="journal"><name><surname>Degen</surname><given-names>J</given-names></name>, <name><surname>Vogel</surname><given-names>M</given-names></name>, <name><surname>Richter</surname><given-names>D</given-names></name>, <name><surname>Hellwig</surname><given-names>M</given-names></name>, <name><surname>Henle</surname><given-names>T</given-names></name> (<year>2013</year>). <article-title>Metabolic transit of dietary methylglyoxal</article-title>. <source/>J Agric Food Chem, <volume>61</volume>: <fpage>10253</fpage>-<lpage>10260</lpage>.<pub-id pub-id-type="pmid">23451712</pub-id></mixed-citation>
</ref>
<ref id="b75-ad-8-3-334">
<label>75.</label>
<mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>K</given-names></name>, <name><surname>Okada</surname><given-names>K</given-names></name>, <name><surname>Fukabori</surname><given-names>R</given-names></name>, <name><surname>Hayashi</surname><given-names>Y</given-names></name>, <name><surname>Asahi</surname><given-names>K</given-names></name> (<year>2014</year>). <article-title>Methylglyoxal (MG) and cerebro-renal interaction: does long-term orally administered MG cause cognitive impairment in normal Sprague-Dawley rats?</article-title>
<source/>Toxins (Basel), <volume>6</volume>: <fpage>254</fpage>-<lpage>269</lpage>.<pub-id pub-id-type="pmid">24402234</pub-id></mixed-citation>
</ref>
<ref id="b76-ad-8-3-334">
<label>76.</label>
<mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>W</given-names></name>, <name><surname>He</surname><given-names>JC</given-names></name>, <name><surname>Zhu</surname><given-names>L</given-names></name>, <etal>et al</etal><year>2008</year>
<article-title>Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related disease and lifespan</article-title>. <source/>Am J Pathol, <volume>173</volume>: <fpage>327</fpage>-<lpage>336</lpage>.<pub-id pub-id-type="pmid">18599606</pub-id></mixed-citation>
</ref>
<ref id="b77-ad-8-3-334">
<label>77.</label>
<mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>W</given-names></name>, <name><surname>Uribarri</surname><given-names>J</given-names></name>, <name><surname>Zhu</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Oral glycotoxins are a modifiable cause of dementia and the metaboilic syndrome in mice and humans</article-title>. <source/>Proc Natl Acad Sci USA, <volume>111</volume>(<issue>13</issue>):<fpage>4940</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="pmid">24567379</pub-id></mixed-citation>
</ref>
<ref id="b78-ad-8-3-334">
<label>78.</label>
<mixed-citation publication-type="journal"><name><surname>West</surname><given-names>R</given-names></name>, <name><surname>Mosher</surname><given-names>E</given-names></name>, <name><surname>Lubitz</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Dietary advanced glycation end products are associated with decline in memory in young elderly. Mech</article-title>. <source/>Ageing Dev, <volume>140</volume>:<fpage>10</fpage>-<lpage>2</lpage></mixed-citation>
</ref>
<ref id="b79-ad-8-3-334">
<label>79.</label>
<mixed-citation publication-type="journal"><name><surname>Sathe</surname><given-names>K</given-names></name>, <name><surname>Maetzler</surname><given-names>W</given-names></name>, <name><surname>Laang</surname><given-names>JD</given-names></name>, <name><surname>Mounsey</surname><given-names>RB</given-names></name>
<etal>et al</etal> (<year>2012</year>). <article-title>S100 is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through RAGE and TNF-alpha pathway</article-title>. <source/>Brain, <volume>135</volume>:<fpage>3336</fpage>-<lpage>3347</lpage>.<pub-id pub-id-type="pmid">23169921</pub-id></mixed-citation>
</ref>
<ref id="b80-ad-8-3-334">
<label>80.</label>
<mixed-citation publication-type="journal"><name><surname>Teismann</surname><given-names>P</given-names></name>, <name><surname>Sathe</surname><given-names>K</given-names></name>, <name><surname>Bierhaus</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Receptor for advanced glycation endproducts (RAGE0 deficiency protects against MPTP toxicity</article-title>. <source/>Neurobiol Aging, <volume>33</volume>: <fpage>2478</fpage>-<lpage>2490</lpage>.<pub-id pub-id-type="pmid">22227007</pub-id></mixed-citation>
</ref>
<ref id="b81-ad-8-3-334">
<label>81.</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>YH</given-names></name>, <name><surname>Yu</surname><given-names>HT</given-names></name>, <name><surname>Pu</surname><given-names>XP</given-names></name>, <name><surname>Du</surname><given-names>GH</given-names></name> (<year>2014</year>). <article-title>Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-KB pathway activation in SH-SY5Y cells</article-title>. <source/>J Mol Neurosci, <volume>53</volume>: <fpage>562</fpage>-<lpage>570</lpage>.<pub-id pub-id-type="pmid">24510749</pub-id></mixed-citation>
</ref>
<ref id="b82-ad-8-3-334">
<label>82.</label>
<mixed-citation publication-type="journal"><name><surname>Natale</surname><given-names>G</given-names></name>, <name><surname>Pasquali</surname><given-names>L</given-names></name>, <name><surname>Paparelli</surname><given-names>A</given-names></name>, <name><surname>Fornai</surname><given-names>F</given-names></name> (<year>2011</year>). <article-title>Parallel manifestations of neuropathologies in the enteric and central nervous systems</article-title>. <source/>Neurogastroenterol Motil
<volume>23</volume>: <fpage>1056</fpage>-<lpage>1065</lpage>.<pub-id pub-id-type="pmid">21951862</pub-id></mixed-citation>
</ref>
<ref id="b83-ad-8-3-334">
<label>83.</label>
<mixed-citation publication-type="journal"><name><surname>Natale</surname><given-names>G</given-names></name>, <name><surname>Pompili</surname><given-names>E</given-names></name>, <name><surname>Biagioni</surname><given-names>F</given-names></name>, <name><surname>Paparelli</surname><given-names>S</given-names></name>
<etal>et al</etal> (<year>2013</year>). <article-title>Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases</article-title>. <source/>Eur J Histochem, <volume>57</volume>: <fpage>e5</fpage>.<pub-id pub-id-type="pmid">23549464</pub-id></mixed-citation>
</ref>
<ref id="b84-ad-8-3-334">
<label>84.</label>
<mixed-citation publication-type="journal"><name><surname>Luk</surname><given-names>KC</given-names></name>, <name><surname>Kehm</surname><given-names>V</given-names></name>, <name><surname>Carroll</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice</article-title>. <source/>Science, <volume>338</volume>: <fpage>949</fpage>-<lpage>953</lpage>.<pub-id pub-id-type="pmid">23161999</pub-id></mixed-citation>
</ref>
<ref id="b85-ad-8-3-334">
<label>85.</label>
<mixed-citation publication-type="journal"><name><surname>Olanow</surname><given-names>CW</given-names></name>, <name><surname>Brundin</surname><given-names>P</given-names></name> (<year>2013</year>). <article-title>Parkinson’s disease and alpha-synuclein: is Parkinson’s disease a prion-like disorder?</article-title>
<source/>Mov Disord, <volume>28</volume>: <fpage>31</fpage>-<lpage>40</lpage>.<pub-id pub-id-type="pmid">23390095</pub-id></mixed-citation>
</ref>
<ref id="b86-ad-8-3-334">
<label>86.</label>
<mixed-citation publication-type="journal"><name><surname>Kovacs</surname><given-names>GG</given-names></name>, <name><surname>Breydo</surname><given-names>L</given-names></name>, <name><surname>Green</surname><given-names>R</given-names></name>, <name><surname>Kis</surname><given-names>V</given-names></name>, <name><surname>Puska</surname><given-names>G</given-names></name>
<etal>et al</etal> (<year>2014</year>). <article-title>Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread</article-title>. <source/>Neurobiol Dis, <volume>69</volume>: <fpage>76</fpage>-<lpage>92</lpage>.<pub-id pub-id-type="pmid">24878508</pub-id></mixed-citation>
</ref>
<ref id="b87-ad-8-3-334">
<label>87.</label>
<mixed-citation publication-type="journal"><name><surname>Reeve</surname><given-names>A</given-names></name>, <name><surname>Meagher</surname><given-names>M</given-names></name>, <name><surname>Lax</surname><given-names>N</given-names></name>
<etal>et al</etal> (<year>2013</year>). <article-title>The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons</article-title>. <source/>J Neurosci, <volume>33</volume>: <fpage>10790</fpage>-<lpage>801</lpage>.<pub-id pub-id-type="pmid">23804100</pub-id></mixed-citation>
</ref>
<ref id="b88-ad-8-3-334">
<label>88.</label>
<mixed-citation publication-type="journal"><name><surname>Reeve</surname><given-names>A</given-names></name>, <name><surname>Simcox</surname><given-names>E</given-names></name>, <name><surname>Turnbull</surname><given-names>D</given-names></name> (<year>2014</year>). <article-title>Ageing and Parkinson’s disease: Why is advancing age the biggest risk factor?</article-title>
<source/>Ageing Res Rev, <volume>14</volume>:<fpage>15</fpage>-<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="b89-ad-8-3-334">
<label>89.</label>
<mixed-citation publication-type="journal"><name><surname>Cook</surname><given-names>C</given-names></name>, <name><surname>Stetler</surname><given-names>C</given-names></name>, <name><surname>Petrucelli</surname><given-names>L</given-names></name> (<year>2012</year>). <article-title>Disruption of protein quality control in Parkinson’s disease</article-title>. <source/>Cold Spring Harb Perspect Med, <volume>2</volume>: <fpage>a009423</fpage>.<pub-id pub-id-type="pmid">22553500</pub-id></mixed-citation>
</ref>
<ref id="b90-ad-8-3-334">
<label>90.</label>
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Duan</surname><given-names>C</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name> (<year>2015</year>). <article-title>Defective autophagy in Parkinson’s disease: lessons from genetics</article-title>. <source/>Mol. Neurobiol, <volume>1</volume>:<fpage>89</fpage>-<lpage>104</lpage></mixed-citation>
</ref>
<ref id="b91-ad-8-3-334">
<label>91.</label>
<mixed-citation publication-type="journal"><name><surname>Nifouro</surname><given-names>K</given-names></name>, <name><surname>Chelmonidou</surname><given-names>C</given-names></name>, <name><surname>Trougakos</surname><given-names>IP</given-names></name> (<year>2014</year>). <article-title>Molecular chaperones and proteostasis regulation during redox imbalance</article-title>. <source/>Redox Biology, <volume>2</volume>: <fpage>323</fpage>-<lpage>332</lpage>.<pub-id pub-id-type="pmid">24563850</pub-id></mixed-citation>
</ref>
<ref id="b92-ad-8-3-334">
<label>92.</label>
<mixed-citation publication-type="journal"><name><surname>Gleixner</surname><given-names>AM</given-names></name>, <name><surname>Pulugulla</surname><given-names>SH</given-names></name>, <name><surname>Pant</surname><given-names>DB</given-names></name>, <name><surname>Posimo</surname><given-names>JM</given-names></name>, <name><surname>Crum</surname><given-names>TS</given-names></name>, <name><surname>Leak</surname><given-names>RK</given-names></name> (<year>2014</year>). <article-title>Impact of aging on heat shock protein expression in the substantia nigra and striatum of the female rat</article-title>. <source/>Cell Tissue Res, <volume>357</volume>(<issue>1</issue>):<fpage>43</fpage>-<lpage>54</lpage><pub-id pub-id-type="pmid">24723229</pub-id></mixed-citation>
</ref>
<ref id="b93-ad-8-3-334">
<label>93.</label>
<mixed-citation publication-type="journal"><name><surname>Kirstein-Miles</surname><given-names>J</given-names></name>, <name><surname>Scior</surname><given-names>A</given-names></name>, <name><surname>Deuerling</surname><given-names>E</given-names></name>, <name><surname>Morimoto</surname><given-names>RI</given-names></name> (<year>2013</year>). <article-title>The nascent polypeptide-associated complex is a key regulator of proteostasis</article-title>. <source/>EMBO J, <volume>32</volume>:<fpage>1451</fpage>-<lpage>1468</lpage>.<pub-id pub-id-type="pmid">23604074</pub-id></mixed-citation>
</ref>
<ref id="b94-ad-8-3-334">
<label>94.</label>
<mixed-citation publication-type="journal"><name><surname>Takino</surname><given-names>J</given-names></name>, <name><surname>Kobayashi</surname><given-names>Y</given-names></name>, <name><surname>Takeuchi</surname><given-names>KJ</given-names></name> (<year>2010</year>). <article-title>The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity</article-title>. <source/>Gastroenterol, <volume>45</volume>, <fpage>646</fpage>-<lpage>655</lpage></mixed-citation>
</ref>
<ref id="b95-ad-8-3-334">
<label>95.</label>
<mixed-citation publication-type="journal"><name><surname>Gawlowski</surname><given-names>T</given-names></name>, <name><surname>Stratmann</surname><given-names>B</given-names></name>, <name><surname>Stork</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Heat shock protein 27 modification is increased in the human diabetic failing heart</article-title>. <source/>Horm Metab Res, <volume>41</volume>: <fpage>594</fpage>-<lpage>599</lpage>.<pub-id pub-id-type="pmid">19384818</pub-id></mixed-citation>
</ref>
<ref id="b96-ad-8-3-334">
<label>96.</label>
<mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>A</given-names></name> (<year>2012</year>). <article-title>Mechanistically linking age-related disease and dietary carbohydrate via autophagy and the ubiquitin proteolytic systems</article-title>. <source/>Autophagy, <volume>8</volume>: <fpage>1404</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">22906982</pub-id></mixed-citation>
</ref>
<ref id="b97-ad-8-3-334">
<label>97.</label>
<mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Lin</surname><given-names>L</given-names></name>, <name><surname>Kan</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>High autophagy in the naked mole rat play a significant role in maintaining good health</article-title>. <source/>Cell Physiol Biochem, <volume>33</volume>: <fpage>321</fpage>-<lpage>332</lpage>.<pub-id pub-id-type="pmid">24525846</pub-id></mixed-citation>
</ref>
<ref id="b98-ad-8-3-334">
<label>98.</label>
<mixed-citation publication-type="journal"><name><surname>Herrero-Mendez</surname><given-names>A</given-names></name>, <name><surname>Almeida</surname><given-names>A</given-names></name>, <name><surname>Fernández</surname><given-names>E</given-names></name>, <name><surname>Maestre</surname><given-names>C</given-names></name>, <name><surname>Moncada</surname><given-names>S</given-names></name>, <name><surname>Bolaños</surname><given-names>JP</given-names></name> (<year>2009</year>). <article-title>The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1</article-title>. <source/>Nat Cell Biol, <volume>11</volume>: <fpage>747</fpage>-<lpage>752</lpage>.<pub-id pub-id-type="pmid">19448625</pub-id></mixed-citation>
</ref>
<ref id="b99-ad-8-3-334">
<label>99.</label>
<mixed-citation publication-type="journal"><name><surname>Rodriguez-Rodriguez</surname><given-names>P</given-names></name>, <name><surname>Fernandez</surname><given-names>E</given-names></name>, <name><surname>Bolaños</surname><given-names>JP</given-names></name> (<year>2013</year>). <article-title>Underestimation of the pentose-phosphate pathway in intact primary neurons as revealed by metabolic flux analysis</article-title>. <source/>J Cereb Blood Flow Metab, <volume>33</volume>:<fpage>1843</fpage>-<lpage>1845</lpage>.<pub-id pub-id-type="pmid">24064491</pub-id></mixed-citation>
</ref>
<ref id="b100-ad-8-3-334">
<label>100.</label>
<mixed-citation publication-type="journal"><name><surname>Almeida</surname><given-names>F</given-names></name>, <name><surname>Santos-Silva</surname><given-names>D</given-names></name>, <name><surname>Rodrigues</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia</article-title>. <source/>Cardiovasc Ther, <volume>31</volume>: <fpage>e79</fpage>-<lpage>85</lpage>.<pub-id pub-id-type="pmid">23841818</pub-id></mixed-citation>
</ref>
<ref id="b101-ad-8-3-334">
<label>101.</label>
<mixed-citation publication-type="journal"><name><surname>Xie</surname><given-names>B</given-names></name>, <name><surname>Lin</surname><given-names>F</given-names></name>, <name><surname>Ullah</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson’s disease</article-title>. <source/>Biochem Biophys Res Commun, <volume>459</volume>: <fpage>361</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">25744031</pub-id></mixed-citation>
</ref>
<ref id="b102-ad-8-3-334">
<label>102.</label>
<mixed-citation publication-type="journal"><name><surname>Luce</surname><given-names>K</given-names></name>, <name><surname>Weil</surname><given-names>AC</given-names></name>, <name><surname>Osiewacz</surname><given-names>HD</given-names></name> (<year>2010</year>). <article-title>Mitochondrial protein quality control systems in aging and disease</article-title>. <source/>Adv Exp Med Biol, <volume>694</volume>: <fpage>108</fpage>-<lpage>125</lpage>.<pub-id pub-id-type="pmid">20886760</pub-id></mixed-citation>
</ref>
<ref id="b103-ad-8-3-334">
<label>103.</label>
<mixed-citation publication-type="journal"><name><surname>Ngo</surname><given-names>JK</given-names></name>, <name><surname>Pomatto</surname><given-names>LC</given-names></name>, <name><surname>Bota</surname><given-names>DE</given-names></name>, <name><surname>Koop</surname><given-names>AL</given-names></name>, <name><surname>Davies</surname><given-names>KJ</given-names></name> (<year>2011</year>). <article-title>Impairment of lon-induced protection against the accumulation of oxidized proteins in senescent wi-38 fibroblasts</article-title>. <source/>J Gerontol A Bio Sci MedSci, <volume>66</volume>: <fpage>1178</fpage>-<lpage>1185</lpage>.</mixed-citation>
</ref>
<ref id="b104-ad-8-3-334">
<label>104.</label>
<mixed-citation publication-type="journal"><name><surname>Ngo</surname><given-names>JK</given-names></name>, <name><surname>Pomatto</surname><given-names>LC</given-names></name>, <name><surname>Davies</surname><given-names>KJ</given-names></name> (<year>2013</year>). <article-title>Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging</article-title>. <source/>Redox Biol, <volume>1</volume>: <fpage>258</fpage>-<lpage>264</lpage>.<pub-id pub-id-type="pmid">24024159</pub-id></mixed-citation>
</ref>
<ref id="b105-ad-8-3-334">
<label>105.</label>
<mixed-citation publication-type="journal"><name><surname>Erjavec</surname><given-names>N</given-names></name>, <name><surname>Bayot</surname><given-names>A</given-names></name>, <name><surname>Gareil</surname><given-names>M</given-names></name>, <name><surname>Camougrand</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>Deletion of the mitochondrial Pim1/Lon protease in yeast results in accelerated aging and impairment of the proteasome</article-title>. <source/>Free Rad Biol Med, <volume>56</volume>: <fpage>9</fpage>-<lpage>16</lpage>.<pub-id pub-id-type="pmid">23220263</pub-id></mixed-citation>
</ref>
<ref id="b106-ad-8-3-334">
<label>106.</label>
<mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Vereshchagina</surname><given-names>N</given-names></name>, <name><surname>Sreekumar</surname><given-names>V</given-names></name>, <name><surname>Burbulla</surname><given-names>LF</given-names></name>
<etal>et al</etal> (<year>2013</year>). <article-title>Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in Drosophila Parkinson’s disease model</article-title>. <source/>PLoS One, <volume>8</volume>: <fpage>e83714</fpage>.<pub-id pub-id-type="pmid">24386261</pub-id></mixed-citation>
</ref>
<ref id="b107-ad-8-3-334">
<label>107.</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>C</given-names></name>, <name><surname>Yen</surname><given-names>K</given-names></name>, <name><surname>Cohen</surname><given-names>P</given-names></name> (<year>2013</year>). <article-title>Humanin: a harbinger of mitochondrial-derived peptides</article-title>. <source/>Trends Endocrinol Metab, <volume>24</volume>: <fpage>222</fpage>-<lpage>228</lpage>.<pub-id pub-id-type="pmid">23402768</pub-id></mixed-citation>
</ref>
<ref id="b108-ad-8-3-334">
<label>108.</label>
<mixed-citation publication-type="journal"><name><surname>Rosenberger</surname><given-names>RF</given-names></name>, <name><surname>Carr</surname><given-names>AJ</given-names></name>, <name><surname>Hipkiss</surname><given-names>AR</given-names></name> (<year>1990</year>). <article-title>Regulation of breakdown of canavanyl proteins in Escherichia coli by growth conditions in lon+ and lon- cells</article-title>. <source/>FEMS Microbiol Lett, <volume>56</volume>: <fpage>19</fpage>-<lpage>25</lpage>.<pub-id pub-id-type="pmid">2185124</pub-id></mixed-citation>
</ref>
<ref id="b109-ad-8-3-334">
<label>109.</label>
<mixed-citation publication-type="journal"><name><surname>Inagi</surname><given-names>R</given-names></name> (<year>2014</year>). <article-title>Glycative stress and glyoxalase in kidney disease and aging</article-title>. <source/>Biochem Soc Trans, <volume>42</volume>: <fpage>457</fpage>-<lpage>60</lpage>.<pub-id pub-id-type="pmid">24646260</pub-id></mixed-citation>
</ref>
<ref id="b110-ad-8-3-334">
<label>110.</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name>, <name><surname>Chana</surname><given-names>H</given-names></name> (<year>1998</year>). <article-title>Carnosine protects proteins against methylglyoxal-mediated modifications</article-title>. <source/>Biochem Biophys Res Commun, <volume>248</volume>:<fpage>28</fpage>-<lpage>32</lpage>.<pub-id pub-id-type="pmid">9675080</pub-id></mixed-citation>
</ref>
<ref id="b111-ad-8-3-334">
<label>111.</label>
<mixed-citation publication-type="journal"><name><surname>Brownson</surname><given-names>C</given-names></name>, <name><surname>Hipkiss</surname><given-names>AR</given-names></name> (<year>2000</year>). <article-title>Carnosine reacts with a glycated protein</article-title>. <source/>Free Radic Biol Med, <volume>28</volume>:<fpage>1564</fpage>-<lpage>70</lpage><pub-id pub-id-type="pmid">10927182</pub-id></mixed-citation>
</ref>
<ref id="b112-ad-8-3-334">
<label>112.</label>
<mixed-citation publication-type="journal"><name><surname>McFarland</surname><given-names>GA</given-names></name>, <name><surname>Holliday</surname><given-names>R</given-names></name> (<year>1994</year>). <article-title>Retardation of the senescence of cultured human diploid fibroblasts by carnosine</article-title>. <source/>Exp Cell Res, <volume>212</volume>:<fpage>167</fpage>-<lpage>75</lpage><pub-id pub-id-type="pmid">8187813</pub-id></mixed-citation>
</ref>
<ref id="b113-ad-8-3-334">
<label>113.</label>
<mixed-citation publication-type="journal"><name><surname>Holliday</surname><given-names>R</given-names></name>, <name><surname>McFarland</surname><given-names>GA</given-names></name> (<year>1996</year>). <article-title>Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine</article-title>. <source/>Br J Cancer, <volume>73</volume>: <fpage>966</fpage>-<lpage>71</lpage><pub-id pub-id-type="pmid">8611433</pub-id></mixed-citation>
</ref>
<ref id="b114-ad-8-3-334">
<label>114.</label>
<mixed-citation publication-type="journal"><name><surname>Renner</surname><given-names>C</given-names></name>, <name><surname>Asperger</surname><given-names>A</given-names></name>, <name><surname>Seyffarth</surname><given-names>A</given-names></name>, <name><surname>Meixensberger</surname><given-names>J</given-names></name>, <name><surname>Gebhardt</surname><given-names>R</given-names></name>, <name><surname>Gaunitz</surname><given-names>F</given-names></name> (<year>2010</year>). <article-title>Carnosine inhibits ATP production in cells from malignant glioma</article-title>. <source/>Neurol Res, <volume>32</volume>:<fpage>101</fpage>-<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="b115-ad-8-3-334">
<label>115.</label>
<mixed-citation publication-type="journal"><name><surname>Kohen</surname><given-names>R</given-names></name>, <name><surname>Yamamoto</surname><given-names>Y</given-names></name>, <name><surname>Cundy</surname><given-names>KC</given-names></name>, <name><surname>Ames</surname><given-names>BN</given-names></name> (<year>1998</year>). <article-title>Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain</article-title>. <source/>Proc Natl Acad Sci USA, <volume>85</volume>: <fpage>3175</fpage>-<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="b116-ad-8-3-334">
<label>116.</label>
<mixed-citation publication-type="journal"><name><surname>Aruoma</surname><given-names>OI</given-names></name>, <name><surname>Laughton</surname><given-names>MJ</given-names></name>, <name><surname>Halliwell</surname><given-names>B</given-names></name> (<year>1989</year>). <article-title>Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo?</article-title>
<source/>Biochem J, <volume>264</volume>: <fpage>863</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="pmid">2559719</pub-id></mixed-citation>
</ref>
<ref id="b117-ad-8-3-334">
<label>117.</label>
<mixed-citation publication-type="journal"><name><surname>Quinn</surname><given-names>PJ</given-names></name>, <name><surname>Boldyrev</surname><given-names>AA</given-names></name>, <name><surname>Formazuyk</surname><given-names>V</given-names></name> (<year>1992</year>). <article-title>Carnosine: its properties, functions and potential therapeutic applications</article-title>. <source/>Mol Aspects Med, <volume>13</volume> :<fpage>379</fpage>-<lpage>444</lpage><pub-id pub-id-type="pmid">9765790</pub-id></mixed-citation>
</ref>
<ref id="b118-ad-8-3-334">
<label>118.</label>
<mixed-citation publication-type="journal"><name><surname>Horning</surname><given-names>MS</given-names></name>, <name><surname>Blakemore</surname><given-names>LJ</given-names></name>, <name><surname>Trombley</surname><given-names>PQ</given-names></name> (<year>2000</year>). <article-title>Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine</article-title>. <source/>Brain Res, <volume>852</volume>:<fpage>56</fpage>-<lpage>61</lpage><pub-id pub-id-type="pmid">10661495</pub-id></mixed-citation>
</ref>
<ref id="b119-ad-8-3-334">
<label>119.</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name>, <name><surname>Michaelis</surname><given-names>J</given-names></name>, <name><surname>Syrris</surname><given-names>P</given-names></name> (<year>1995</year>). <article-title>Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent</article-title>. <source/>FEBS Lett, <volume>371</volume>: <fpage>81</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="pmid">7664889</pub-id></mixed-citation>
</ref>
<ref id="b120-ad-8-3-334">
<label>120.</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name>, <name><surname>Preston</surname><given-names>JE</given-names></name>, <name><surname>Himsworth</surname><given-names>DT</given-names></name>, <etal>et al</etal> (<year>1998</year>). <article-title>Pluripotent protective effects of carnosine, a naturally occurring dipeptide</article-title>. <source/>Ann N Y Acad Sci, <volume>854</volume>:<fpage>37</fpage>-<lpage>53</lpage>.<pub-id pub-id-type="pmid">9928418</pub-id></mixed-citation>
</ref>
<ref id="b121-ad-8-3-334">
<label>121.</label>
<mixed-citation publication-type="journal"><name><surname>Aldini</surname><given-names>G</given-names></name>, <name><surname>Orioli</surname><given-names>M</given-names></name>, <name><surname>Rossoni</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats</article-title>. <source/>J Cell Mol Med, <volume>15</volume>:<fpage>1339</fpage>-<lpage>54</lpage>.<pub-id pub-id-type="pmid">20518851</pub-id></mixed-citation>
</ref>
<ref id="b122-ad-8-3-334">
<label>122.</label>
<mixed-citation publication-type="journal"><name><surname>Seidler</surname><given-names>NW</given-names></name> (<year>2000</year>). <article-title>Carnosine prevents the glycation-induced changes in electrophoretic mobility of aspartate aminotransferase</article-title>. <source/>J Biochem Mol Toxicol, <volume>14</volume>: <fpage>215</fpage>-<lpage>20</lpage>.<pub-id pub-id-type="pmid">10789500</pub-id></mixed-citation>
</ref>
<ref id="b123-ad-8-3-334">
<label>123.</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>G</given-names></name>, <name><surname>Sayre</surname><given-names>LM</given-names></name> (<year>2003</year>). <article-title>Carnosine inhibits (E)-4-hydroxy-2-nonenal-induced protein cross-linking: structural characterization of carnosine-HNE adducts</article-title>. <source/>Chem Res Toxicol, <volume>16</volume>:<fpage>1589</fpage>-<lpage>97</lpage>.<pub-id pub-id-type="pmid">14680373</pub-id></mixed-citation>
</ref>
<ref id="b124-ad-8-3-334">
<label>124.</label>
<mixed-citation publication-type="journal"><name><surname>Hipkiss</surname><given-names>AR</given-names></name> (<year>2014</year>). <article-title>Aging risk factors and Parkinson's disease: contrasting roles of common dietary constituents</article-title>. <source/>Neurobiol Aging, <volume>35</volume>:<fpage>1469</fpage>-<lpage>72</lpage><pub-id pub-id-type="pmid">24388766</pub-id></mixed-citation>
</ref>
<ref id="b125-ad-8-3-334">
<label>125.</label>
<mixed-citation publication-type="journal"><name><surname>Bellia</surname><given-names>F</given-names></name>, <name><surname>Vecchio</surname><given-names>G</given-names></name>, <name><surname>Rizzarelli</surname><given-names>E</given-names></name>. (<year>2014</year>). <article-title>Carnosinases, their substrates and diseases</article-title>. <source/>Molecules.
<volume>19</volume>: <fpage>2299</fpage>-<lpage>329</lpage>.<pub-id pub-id-type="pmid">24566305</pub-id></mixed-citation>
</ref>
<ref id="b126-ad-8-3-334">
<label>126.</label>
<mixed-citation publication-type="journal"><name><surname>Boldyrev</surname><given-names>AA</given-names></name>, <name><surname>Aldini</surname><given-names>G</given-names></name>, <name><surname>Derave</surname><given-names>W</given-names></name> (<year>2013</year>). <article-title>Physiology and pathophysiology of carnosine</article-title>. <source/>Physiol Rev, <volume>93</volume>:<fpage>1803</fpage>-<lpage>45</lpage>.<pub-id pub-id-type="pmid">24137022</pub-id></mixed-citation>
</ref>
<ref id="b127-ad-8-3-334">
<label>127.</label>
<mixed-citation publication-type="journal"><name><surname>Peters</surname><given-names>V</given-names></name>, <name><surname>Lanthaler</surname><given-names>B</given-names></name>, <name><surname>Amberger</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>Carnosine metabolism in diabetes is altered by reactive metabolites</article-title>. <source/>Amino Acids, <volume>47</volume>: <fpage>2367</fpage>-<lpage>76</lpage><pub-id pub-id-type="pmid">26081982</pub-id></mixed-citation>
</ref>
<ref id="b128-ad-8-3-334">
<label>128.</label>
<mixed-citation publication-type="journal"><name><surname>Peters</surname><given-names>V</given-names></name>, <name><surname>Schmitt</surname><given-names>CP</given-names></name>, <name><surname>Zschocke</surname><given-names>J</given-names></name>, <name><surname>Gross</surname><given-names>ML</given-names></name>, <name><surname>Brismar</surname><given-names>K</given-names></name>, <name><surname>Forsberg</surname><given-names>E</given-names></name>. (<year>2012</year>). <article-title>Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice</article-title>. <source/>Amino Acids, <volume>42</volume>: <fpage>2411</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">21833769</pub-id></mixed-citation>
</ref>
<ref id="b129-ad-8-3-334">
<label>129.</label>
<mixed-citation publication-type="journal"><name><surname>Bellia</surname><given-names>F</given-names></name>, <name><surname>Calabrese</surname><given-names>V</given-names></name>, <name><surname>Guarino</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Carnosinase levels in aging brain: redox state induction and cellular stress response</article-title>. <source/>Antioxid Redox Signal, <volume>11</volume>: <fpage>2759</fpage>-<lpage>75</lpage>.<pub-id pub-id-type="pmid">19583493</pub-id></mixed-citation>
</ref>
<ref id="b130-ad-8-3-334">
<label>130.</label>
<mixed-citation publication-type="journal"><name><surname>Licker</surname><given-names>V</given-names></name>, <name><surname>Côte</surname><given-names>M</given-names></name>, <name><surname>Lobrinus</surname><given-names>JA</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease</article-title>. <source/>J Proteomics, <volume>75</volume>: <fpage>4656</fpage>-<lpage>67</lpage>.<pub-id pub-id-type="pmid">22410244</pub-id></mixed-citation>
</ref>
<ref id="b131-ad-8-3-334">
<label>131.</label>
<mixed-citation publication-type="journal"><name><surname>Stvolinskii</surname><given-names>SL</given-names></name>, <name><surname>Fedorova</surname><given-names>TN</given-names></name>, <name><surname>Yuneva</surname><given-names>MO</given-names></name>, <name><surname>Boldyrev</surname><given-names>AA</given-names></name> (<year>2003</year>). <article-title>Protective effect of carnosine on Cu, Zn-superoxide dismutase during impaired oxidative metabolism in the brain in vivo</article-title>. <source/>Bull Exp Biol Med, <volume>135</volume>:<fpage>130</fpage>-<lpage>2</lpage>.</mixed-citation>
</ref>
<ref id="b132-ad-8-3-334">
<label>132.</label>
<mixed-citation publication-type="journal"><name><surname>Cararo</surname><given-names>JH</given-names></name>, <name><surname>Streck</surname><given-names>EL</given-names></name>, <name><surname>Schuck</surname><given-names>PF</given-names></name>, <name><surname>Ferreira</surname><given-names>GC</given-names></name> (<year>2015</year>). <article-title>Carnosine and related peptides: therapeutic potential in age-related disorders</article-title>. <source/>Aging Dis, <volume>6</volume> :<fpage>369</fpage>-<lpage>79</lpage>.<pub-id pub-id-type="pmid">26425391</pub-id></mixed-citation>
</ref>
<ref id="b133-ad-8-3-334">
<label>133.</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Su</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Wei</surname><given-names>S</given-names></name>, <name><surname>Liu</surname><given-names>K</given-names></name>, <name><surname>Peng</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name> (<year>2016</year>). <article-title>Endogenous L-Carnosine Level in Diabetes Rat Cardiac Muscle</article-title>. <source/>Evid Based Complement Alternat Med, <volume>2016</volume>:<fpage>6230825</fpage>.<pub-id pub-id-type="pmid">27190533</pub-id></mixed-citation>
</ref>
<ref id="b134-ad-8-3-334">
<label>134.</label>
<mixed-citation publication-type="journal"><name><surname>Menini</surname><given-names>S</given-names></name>, <name><surname>Iacobini</surname><given-names>C</given-names></name>, <name><surname>Ricci</surname><given-names>C</given-names></name>, <name><surname>Blasetti Fantauzzi</surname><given-names>C</given-names></name>, <name><surname>Pugliese</surname><given-names>G</given-names></name> (<year>2015</year>). <article-title>Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice</article-title>. <source/>Diabetologia, <volume>58</volume>: <fpage>845</fpage>-<lpage>53</lpage>.<pub-id pub-id-type="pmid">25471794</pub-id></mixed-citation>
</ref>
<ref id="b135-ad-8-3-334">
<label>135.</label>
<mixed-citation publication-type="journal"><name><surname>Riedl</surname><given-names>E</given-names></name>, <name><surname>Pfister</surname><given-names>F</given-names></name>, <name><surname>Braunagel</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats</article-title>. <source/>Cell Physiol Biochem, <volume>28</volume>: <fpage>279</fpage>-<lpage>88</lpage><pub-id pub-id-type="pmid">21865735</pub-id></mixed-citation>
</ref>
<ref id="b136-ad-8-3-334">
<label>136.</label>
<mixed-citation publication-type="journal"><name><surname>Janssen</surname><given-names>B</given-names></name>, <name><surname>Hohenadel</surname><given-names>D</given-names></name>, <name><surname>Brinkkoetter</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2005</year>). <article-title>Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1</article-title>. <source/>Diabetes, <volume>54</volume>: <fpage>2320</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">16046297</pub-id></mixed-citation>
</ref>
<ref id="b137-ad-8-3-334">
<label>137.</label>
<mixed-citation publication-type="journal"><name><surname>Baye</surname><given-names>E</given-names></name>, <name><surname>Ukropcova</surname><given-names>B</given-names></name>, <name><surname>Ukropec</surname><given-names>J</given-names></name>, <name><surname>Hipkiss</surname><given-names>A</given-names></name>, <name><surname>Aldini</surname><given-names>G</given-names></name>, <name><surname>de Courten</surname><given-names>B</given-names></name> (<year>2016</year>). <article-title>Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease</article-title>. <source/>Amino Acids, <volume>48</volume>:<fpage>1131</fpage>-<lpage>49</lpage><pub-id pub-id-type="pmid">26984320</pub-id></mixed-citation>
</ref>
<ref id="b138-ad-8-3-334">
<label>138.</label>
<mixed-citation publication-type="journal"><name><surname>Brown</surname><given-names>BE</given-names></name>, <name><surname>Kim</surname><given-names>CH</given-names></name>, <name><surname>Torpy</surname><given-names>FR</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice</article-title>. <source/>Atherosclerosis, <volume>232</volume> :<fpage>403</fpage>-<lpage>9</lpage><pub-id pub-id-type="pmid">24468155</pub-id></mixed-citation>
</ref>
<ref id="b139-ad-8-3-334">
<label>139.</label>
<mixed-citation publication-type="journal"><name><surname>Barski</surname><given-names>OA</given-names></name>, <name><surname>Xie</surname><given-names>Z</given-names></name>, <name><surname>Baba</surname><given-names>SP</given-names></name>, <name><surname>Sithu</surname><given-names>SD</given-names></name>, <name><surname>Agarwal</surname><given-names>A</given-names></name>, <name><surname>Cai</surname><given-names>J</given-names></name>, <name><surname>Bhatnagar</surname><given-names>A</given-names></name>, <name><surname>Srivastava</surname><given-names>S</given-names></name>. (<year>2013</year>). <article-title>Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice</article-title>. <source/>Arterioscler Thromb Vasc Biol, <volume>33</volume>: <fpage>1162</fpage>-<lpage>70</lpage>.<pub-id pub-id-type="pmid">23559625</pub-id></mixed-citation>
</ref>
<ref id="b140-ad-8-3-334">
<label>140.</label>
<mixed-citation publication-type="journal"><name><surname>Abdelkader</surname><given-names>H</given-names></name>, <name><surname>Swinden</surname><given-names>J</given-names></name>, <name><surname>Pierscionek</surname><given-names>BK</given-names></name>, <name><surname>Alany</surname><given-names>RG</given-names></name>. (<year>2015</year>). <article-title>Analytical and physicochemical characterisation of the senile cataract drug dipeptide β-alanyl-L-histidine (carnosine)</article-title>. <source/>J Pharm Biomed Anal, <volume>114</volume>:<fpage>241</fpage>-<lpage>6</lpage><pub-id pub-id-type="pmid">26073114</pub-id></mixed-citation>
</ref>
<ref id="b141-ad-8-3-334">
<label>141.</label>
<mixed-citation publication-type="journal"><name><surname>Villari</surname><given-names>V</given-names></name>, <name><surname>Attanasio</surname><given-names>F</given-names></name>, <name><surname>Micali</surname><given-names>N</given-names></name> (<year>2014</year>). <article-title>Control of the structural stability of α-crystallin under thermal and chemical stress: the role of carnosine</article-title>. <source/>J Phys Chem B, <volume>118</volume>: <fpage>13770</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">25356752</pub-id></mixed-citation>
</ref>
<ref id="b142-ad-8-3-334">
<label>142.</label>
<mixed-citation publication-type="journal"><name><surname>Babizhayev</surname><given-names>MA</given-names></name>, <name><surname>Yegorov</surname><given-names>YE</given-names></name> (<year>2014</year>). <article-title>Biomarkers of oxidative stress and cataract. Novel drug delivery therapeutic strategies targeting telomere reduction and the expression of telomerase activity in the lens epithelial cells with N-acetylcarnosine lubricant eye drops: anti-cataract which helps to prevent and treat cataracts in the eyes of dogs and other animals</article-title>. <source/>Curr Drug Deliv, <volume>11</volume>: <fpage>24</fpage>-<lpage>61</lpage>.<pub-id pub-id-type="pmid">24783234</pub-id></mixed-citation>
</ref>
<ref id="b143-ad-8-3-334">
<label>143.</label>
<mixed-citation publication-type="journal"><name><surname>Dizhevskaya</surname><given-names>AK</given-names></name>, <name><surname>Muranov</surname><given-names>KO</given-names></name>, <name><surname>Boldyrev</surname><given-names>AA</given-names></name>, <name><surname>Ostrovsky</surname><given-names>MA</given-names></name> (<year>2012</year>). <article-title>Natural dipeptides as mini-chaperones: molecular mechanism of inhibition of lens βL-crystallin aggregation</article-title>. <source/>Curr Aging Sci, <volume>5</volume>:<fpage>236</fpage>-<lpage>41</lpage><pub-id pub-id-type="pmid">23387882</pub-id></mixed-citation>
</ref>
<ref id="b144-ad-8-3-334">
<label>144.</label>
<mixed-citation publication-type="journal"><name><surname>Babizhayev</surname><given-names>MA</given-names></name> (<year>2006</year>). <article-title>Biological activities of the natural imidazole-containing peptidomimetics n-acetylcarnosine, carcinine and L-carnosine in ophthalmic and skin care products</article-title>. <source/>Life Sci, <volume>78</volume>: <fpage>2343</fpage>-<lpage>57</lpage><pub-id pub-id-type="pmid">16388826</pub-id></mixed-citation>
</ref>
<ref id="b145-ad-8-3-334">
<label>145.</label>
<mixed-citation publication-type="journal"><name><surname>Baek</surname><given-names>SH</given-names></name>, <name><surname>Noh</surname><given-names>AR</given-names></name>, <name><surname>Kim</surname><given-names>KA</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage</article-title>. <source/>Stroke, <volume>45</volume>: <fpage>2438</fpage>-<lpage>43</lpage><pub-id pub-id-type="pmid">24938837</pub-id></mixed-citation>
</ref>
<ref id="b146-ad-8-3-334">
<label>146.</label>
<mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>HS</given-names></name>, <name><surname>Han</surname><given-names>KH</given-names></name>, <name><surname>Shin</surname><given-names>JA</given-names></name>, <name><surname>Park</surname><given-names>JH</given-names></name>, <name><surname>Song</surname><given-names>KY</given-names></name>, <name><surname>Kim</surname><given-names>DH</given-names></name> (<year>2014</year>). <article-title>The neuroprotective effects of carnosine in early stage of focal ischemia rodent model</article-title>. <source/>J Korean Neurosurg Soc, <volume>55</volume>:<fpage>125</fpage>-<lpage>30</lpage><pub-id pub-id-type="pmid">24851146</pub-id></mixed-citation>
</ref>
<ref id="b147-ad-8-3-334">
<label>147.</label>
<mixed-citation publication-type="journal"><name><surname>Bae</surname><given-names>ON</given-names></name>, <name><surname>Majid</surname><given-names>A</given-names></name>. (<year>2013</year>). <article-title>Role of histidine/histamine in carnosine-induced neuroprotection during ischemic brain damage</article-title>. <source/>Brain Res, <volume>1527</volume>: <fpage>246</fpage>-<lpage>54</lpage>.<pub-id pub-id-type="pmid">23850642</pub-id></mixed-citation>
</ref>
<ref id="b148-ad-8-3-334">
<label>148.</label>
<mixed-citation publication-type="journal"><name><surname>Rajanikant</surname><given-names>GK</given-names></name>, <name><surname>Zemke</surname><given-names>D</given-names></name>, <name><surname>Senut</surname><given-names>MC</given-names></name>, <name><surname>Frenkel</surname><given-names>MB</given-names></name>, <name><surname>Chen</surname><given-names>AF</given-names></name>, <name><surname>Gupta</surname><given-names>R</given-names></name>, <name><surname>Majid</surname><given-names>A</given-names></name>. (<year>2007</year>). <article-title>Carnosine is neuroprotective against permanent focal cerebral ischemia in mice</article-title>. <source/>Stroke, <volume>38</volume>: <fpage>3023</fpage>-<lpage>31</lpage><pub-id pub-id-type="pmid">17916766</pub-id></mixed-citation>
</ref>
<ref id="b149-ad-8-3-334">
<label>149.</label>
<mixed-citation publication-type="journal"><name><surname>Aloisi</surname><given-names>A</given-names></name>, <name><surname>Barca</surname><given-names>A</given-names></name>, <name><surname>Romano</surname><given-names>A</given-names></name>, <name><surname>Guerrieri</surname><given-names>S</given-names></name>, <name><surname>Storelli</surname><given-names>C</given-names></name>, <name><surname>Rinaldi</surname><given-names>R</given-names></name>, <name><surname>Verri</surname><given-names>T</given-names></name> (<year>2013</year>). <article-title>The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats</article-title>. <source/>PLoS One, <volume>8</volume>: <fpage>e68159</fpage>.<pub-id pub-id-type="pmid">23844165</pub-id></mixed-citation>
</ref>
<ref id="b150-ad-8-3-334">
<label>150.</label>
<mixed-citation publication-type="journal"><name><surname>Corona</surname><given-names>C</given-names></name>, <name><surname>Frazzini</surname><given-names>V</given-names></name>, <name><surname>Silvestri</surname><given-names>E</given-names></name>, <name><surname>Lattanzio</surname><given-names>R</given-names></name>, <name><surname>La Sorda</surname><given-names>R</given-names></name>, <name><surname>Piantelli</surname><given-names>M</given-names></name>, <name><surname>Canzoniero</surname><given-names>LM</given-names></name>, <name><surname>Ciavardelli</surname><given-names>D</given-names></name>, <name><surname>Rizzarelli</surname><given-names>E</given-names></name>, <name><surname>Sensi</surname><given-names>SL</given-names></name> (<year>2011</year>). <article-title>Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice</article-title>. <source/>PLoS One, <volume>6</volume>(<issue>3</issue>): <fpage>e17971</fpage>.<pub-id pub-id-type="pmid">21423579</pub-id></mixed-citation>
</ref>
<ref id="b151-ad-8-3-334">
<label>151.</label>
<mixed-citation publication-type="journal"><name><surname>Attanasio</surname><given-names>F</given-names></name>, <name><surname>Convertino</surname><given-names>M</given-names></name>, <name><surname>Magno</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>Carnosine inhibits Aβ(42) aggregation by perturbing the H-bond network in and around the central hydrophobic cluster</article-title>. <source/>Chem Biochem, <volume>14</volume>: <fpage>583</fpage>-<lpage>92</lpage>.</mixed-citation>
</ref>
<ref id="b152-ad-8-3-334">
<label>152.</label>
<mixed-citation publication-type="journal"><name><surname>Afshin-Majd</surname><given-names>S</given-names></name>, <name><surname>Khalili</surname><given-names>M</given-names></name>, <name><surname>Roghani</surname><given-names>M</given-names></name>, <name><surname>Mehranmehr</surname><given-names>N</given-names></name>, <name><surname>Baluchnejadmojarad</surname><given-names>T</given-names></name> (<year>2015</year>). <article-title>Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat</article-title>. <source/>Mol Neurobiol, <volume>51</volume>:<fpage>1064</fpage>-<lpage>70</lpage>.<pub-id pub-id-type="pmid">24939694</pub-id></mixed-citation>
</ref>
<ref id="b153-ad-8-3-334">
<label>153.</label>
<mixed-citation publication-type="journal"><name><surname>Tsai</surname><given-names>SJ</given-names></name>, <name><surname>Kuo</surname><given-names>WW</given-names></name>, <name><surname>Liu</surname><given-names>WH</given-names></name>, <name><surname>Yin</surname><given-names>MC</given-names></name> (<year>2010</year>). <article-title>Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice</article-title>. <source/>J Agric Food Chem, <volume>58</volume>: <fpage>11510</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">20925384</pub-id></mixed-citation>
</ref>
<ref id="b154-ad-8-3-334">
<label>154.</label>
<mixed-citation publication-type="journal"><name><surname>Boldyrev</surname><given-names>A</given-names></name>, <name><surname>Fedorova</surname><given-names>T</given-names></name>, <name><surname>Stepanova</surname><given-names>M</given-names></name>, <name><surname>Dobrotvorskaya</surname><given-names>I</given-names></name>, <name><surname>Kozlova</surname><given-names>E</given-names></name>, <name><surname>Boldanova</surname><given-names>N</given-names></name>, <name><surname>Bagyeva</surname><given-names>G</given-names></name>, <name><surname>Ivanova-Smolenskaya</surname><given-names>I</given-names></name>, <name><surname>Illarioshkin</surname><given-names>S</given-names></name> (<year>2008</year>). <article-title>Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study</article-title>. <source/>Rejuvenation Res, <volume>11</volume>: <fpage>821</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">18729814</pub-id></mixed-citation>
</ref>
<ref id="b155-ad-8-3-334">
<label>155.</label>
<mixed-citation publication-type="journal"><name><surname>Chez</surname><given-names>MG</given-names></name>, <name><surname>Buchanan</surname><given-names>CP</given-names></name>, <name><surname>Aimonovitch</surname><given-names>MC</given-names></name>, <name><surname>Becker</surname><given-names>M</given-names></name>, <name><surname>Schaefer</surname><given-names>K</given-names></name>, <name><surname>Black</surname><given-names>C</given-names></name>, <name><surname>Komen</surname><given-names>J</given-names></name>. (<year>2002</year>). <article-title>Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders</article-title>. <source/>J Child Neurol, <volume>17</volume>: <fpage>833</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">12585724</pub-id></mixed-citation>
</ref>
<ref id="b156-ad-8-3-334">
<label>156.</label>
<mixed-citation publication-type="journal"><name><surname>Chengappa</surname><given-names>KN</given-names></name>, <name><surname>Turkin</surname><given-names>SR</given-names></name>, <name><surname>DeSanti</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia</article-title>. <source/>Schizophr Res, <volume>142</volume>:<fpage>145</fpage>-<lpage>52</lpage>.<pub-id pub-id-type="pmid">23099060</pub-id></mixed-citation>
</ref>
<ref id="b157-ad-8-3-334">
<label>157.</label>
<mixed-citation publication-type="journal"><name><surname>Lombardi</surname><given-names>C</given-names></name>, <name><surname>Carubelli</surname><given-names>V</given-names></name>, <name><surname>Lazzarini</surname><given-names>V</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure</article-title>. <source/>Nutrition, <volume>31</volume>:<fpage>72</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">25287762</pub-id></mixed-citation>
</ref>
<ref id="b158-ad-8-3-334">
<label>158.</label>
<mixed-citation publication-type="journal"><name><surname>Baraniuk</surname><given-names>JN</given-names></name>, <name><surname>El-Amin</surname><given-names>S</given-names></name>, <name><surname>Corey</surname><given-names>R</given-names></name>, <name><surname>Rayhan</surname><given-names>R</given-names></name>, <name><surname>Timbol</surname><given-names>C</given-names></name> (<year>2013</year>). <article-title>Carnosine treatment for gulf war illness: a randomized controlled trial</article-title>. <source/>Glob J Health Sci, <volume>5</volume>: <fpage>69</fpage>-<lpage>81</lpage>.<pub-id pub-id-type="pmid">23618477</pub-id></mixed-citation>
</ref>
<ref id="b159-ad-8-3-334">
<label>159.</label>
<mixed-citation publication-type="journal"><name><surname>Szcześniak</surname><given-names>D</given-names></name>, <name><surname>Budzeń</surname><given-names>S</given-names></name>, <name><surname>Kopeć</surname><given-names>W</given-names></name>, <name><surname>Rymaszewska</surname><given-names>J</given-names></name> (<year>2014</year>). <article-title>Anserine and carnosine supplementation in the elderly: Effects on cognitive functioning and physical capacity</article-title>. <source/>Arch Gerontol Geriatr, <volume>59</volume>:<fpage>485</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="pmid">24880197</pub-id></mixed-citation>
</ref>
<ref id="b160-ad-8-3-334">
<label>160.</label>
<mixed-citation publication-format="print" publication-type="book"><name><surname>Hayflick</surname><given-names>L</given-names></name> (<year>1987</year>). <article-title>Origins of longevity</article-title>. In: <name><surname>Warner</surname><given-names>HR</given-names></name>, <name><surname>Butler</surname><given-names>RN</given-names></name>, <name><surname>Sprott</surname><given-names>RL</given-names></name>, <name><surname>Schneider</surname><given-names>EL</given-names></name>, editors. <source/>Modern biological theories of aging., <publisher-loc>New York</publisher-loc>: <publisher-name>Raven Press</publisher-name>, <fpage>21</fpage>-<lpage>34</lpage>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>